{
"instance": {
"lh202010-qq1projectfile.htm": {
"axisCustom": 1,
"axisStandard": 19,
"contextCount": 255,
"dts": {
"calculationLink": {
"local": [
"lh-20200331_cal.xml"
]
},
"definitionLink": {
"local": [
"lh-20200331_def.xml"
],
"remote": [
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
"http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
]
},
"inline": {
"local": [
"lh202010-qq1projectfile.htm"
]
},
"labelLink": {
"local": [
"lh-20200331_lab.xml"
],
"remote": [
"https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml"
]
},
"presentationLink": {
"local": [
"lh-20200331_pre.xml"
]
},
"referenceLink": {
"remote": [
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml",
"https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
]
},
"schema": {
"local": [
"lh-20200331.xsd"
],
"remote": [
"http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
"http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
"http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
"https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
"http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
"https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
"https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
"https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
"http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
"http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
"https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
"http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
"http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
"http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
]
}
},
"elementCount": 618,
"entityCount": 1,
"hidden": {
"http://fasb.org/us-gaap/2019-01-31": 2,
"http://xbrl.sec.gov/dei/2019-01-31": 5,
"total": 7
},
"keyCustom": 80,
"keyStandard": 342,
"memberCustom": 25,
"memberStandard": 51,
"nsprefix": "lh",
"nsuri": "http://www.labcorp.com/20200331",
"report": {
"R1": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "document",
"isDefault": "true",
"longName": "0001000 - Document - Cover Page",
"role": "http://www.labcorp.com/role/CoverPage",
"shortName": "Cover Page",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R10": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2104100 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES",
"role": "http://www.labcorp.com/role/RestructuringAndOtherSpecialCharges",
"shortName": "RESTRUCTURING AND OTHER SPECIAL CHARGES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R11": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2106100 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
"role": "http://www.labcorp.com/role/GoodwillAndIntangibleAssets",
"shortName": "GOODWILL AND INTANGIBLE ASSETS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R12": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DebtDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2107100 - Disclosure - DEBT",
"role": "http://www.labcorp.com/role/Debt",
"shortName": "DEBT",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:DebtDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R13": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2108100 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY",
"role": "http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquity",
"shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "lh:ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R14": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:IncomeTaxDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2109100 - Disclosure - INCOME TAXES",
"role": "http://www.labcorp.com/role/IncomeTaxes",
"shortName": "INCOME TAXES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:IncomeTaxDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R15": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2110100 - Disclosure - COMMITMENTS AND CONTINGENCIES",
"role": "http://www.labcorp.com/role/CommitmentsAndContingencies",
"shortName": "COMMITMENTS AND CONTINGENCIES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R16": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
"reportCount": 1,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2111100 - Disclosure - PENSION AND POSTRETIREMENT PLANS",
"role": "http://www.labcorp.com/role/PensionAndPostretirementPlans",
"shortName": "PENSION AND POSTRETIREMENT PLANS",
"subGroupType": "",
"uniqueAnchor": null
},
"R17": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueDisclosuresTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2112100 - Disclosure - FAIR VALUE MEASUREMENTS",
"role": "http://www.labcorp.com/role/FairValueMeasurements",
"shortName": "FAIR VALUE MEASUREMENTS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueDisclosuresTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R18": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2113100 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
"role": "http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivities",
"shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R19": {
"firstAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
"reportCount": 1,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2114100 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION",
"role": "http://www.labcorp.com/role/SupplementalCashFlowInformation",
"shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
"subGroupType": "",
"uniqueAnchor": null
},
"R2": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AccountsPayableCurrent",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1001000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
"role": "http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"lang": null,
"name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R20": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BusinessCombinationDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2115100 - Disclosure - BUSINESS ACQUISITIONS",
"role": "http://www.labcorp.com/role/BusinessAcquisitions",
"shortName": "BUSINESS ACQUISITIONS",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BusinessCombinationDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R21": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SegmentReportingDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2117100 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment information (Notes)",
"role": "http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationNotes",
"shortName": "BUSINESS SEGMENT INFORMATION Business Segment information (Notes)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SegmentReportingDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R22": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:UseOfEstimates",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2201201 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Use of Estimates (Policies)",
"role": "http://www.labcorp.com/role/BasisOfFinancialStatementPresentationUseOfEstimatesPolicies",
"shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION Use of Estimates (Policies)",
"subGroupType": "policies",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:UseOfEstimates",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R23": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2201202 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION New Accounting Pronouncements (Policies)",
"role": "http://www.labcorp.com/role/BasisOfFinancialStatementPresentationNewAccountingPronouncementsPolicies",
"shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION New Accounting Pronouncements (Policies)",
"subGroupType": "policies",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R24": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "lh:NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2201203 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Novel Coronavirus (COVID-19) Financial Statement Impact (Policies)",
"role": "http://www.labcorp.com/role/BasisOfFinancialStatementPresentationNovelCoronavirusCovid19FinancialStatementImpactPolicies",
"shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION Novel Coronavirus (COVID-19) Financial Statement Impact (Policies)",
"subGroupType": "policies",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "lh:NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R25": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "lh:RecentlyAdoptedAccountingGuidancePolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2201204 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Recently Adopted Accounting Standards (Policies)",
"role": "http://www.labcorp.com/role/BasisOfFinancialStatementPresentationRecentlyAdoptedAccountingStandardsPolicies",
"shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION Recently Adopted Accounting Standards (Policies)",
"subGroupType": "policies",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "lh:RecentlyAdoptedAccountingGuidancePolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R26": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2302301 - Disclosure - EARNINGS PER SHARE (Tables)",
"role": "http://www.labcorp.com/role/EarningsPerShareTables",
"shortName": "EARNINGS PER SHARE (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R27": {
"firstAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2304301 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES Restructuring and Other Special Charges Detail (Tables)",
"role": "http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables",
"shortName": "RESTRUCTURING AND OTHER SPECIAL CHARGES Restructuring and Other Special Charges Detail (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R28": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfGoodwillTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2306301 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
"role": "http://www.labcorp.com/role/GoodwillAndIntangibleAssetsTables",
"shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfGoodwillTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R29": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2312301 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
"role": "http://www.labcorp.com/role/FairValueMeasurementsTables",
"shortName": "FAIR VALUE MEASUREMENTS (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R3": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"ix:continuation",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1001501 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)",
"role": "http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals",
"shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals)",
"subGroupType": "parenthetical",
"uniqueAnchor": null
},
"R30": {
"firstAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
"reportCount": 1,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2314301 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Tables)",
"role": "http://www.labcorp.com/role/SupplementalCashFlowInformationTables",
"shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Tables)",
"subGroupType": "tables",
"uniqueAnchor": null
},
"R31": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2315301 - Disclosure - BUSINESS ACQUISITIONS Business Acquisitions Tables (Tables)",
"role": "http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables",
"shortName": "BUSINESS ACQUISITIONS Business Acquisitions Tables (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R32": {
"firstAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2316301 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
"role": "http://www.labcorp.com/role/BusinessSegmentInformationTables",
"shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R33": {
"firstAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2318301 - Disclosure - REVENUE (Tables)",
"role": "http://www.labcorp.com/role/RevenueTables",
"shortName": "REVENUE (Tables)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R34": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
"reportCount": 1,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2320301 - Disclosure - Leases (Tables)",
"role": "http://www.labcorp.com/role/LeasesTables",
"shortName": "Leases (Tables)",
"subGroupType": "tables",
"uniqueAnchor": null
},
"R35": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AssetImpairmentCharges",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2401406 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)",
"role": "http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"lh:NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"lang": null,
"name": "us-gaap:ImpairmentOfInvestments",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R36": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2402402 - Disclosure - EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)",
"role": "http://www.labcorp.com/role/EarningsPerShareReconciliationOfBasicEarningsPerShareToDilutedEarningsPerShareDetails",
"shortName": "EARNINGS PER SHARE (Reconciliation of Basic Earnings Per Share to Diluted Earnings Per Share) (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"lang": null,
"name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R37": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"ix:continuation",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2402403 - Disclosure - EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)",
"role": "http://www.labcorp.com/role/EarningsPerSharePotentialCommonSharesNotIncludedInComputationOfDilutedEarningsPerShareDetails",
"shortName": "EARNINGS PER SHARE (Potential common shares not included in computation of diluted earnings per share) (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"ix:continuation",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R38": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"ix:continuation",
"us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:RestructuringReserve",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2404402 - Disclosure - RESTRUCTURING AND OTHER SPECIAL CHARGES (Details)",
"role": "http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"shortName": "RESTRUCTURING AND OTHER SPECIAL CHARGES (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"lang": null,
"name": "lh:NetRestructuringCharges",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R39": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "lh:Unusedfacilityrestructuringreserves",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2405401 - Disclosure - RESTRUCTURING RESERVES (Details)",
"role": "http://www.labcorp.com/role/RestructuringReservesDetails",
"shortName": "RESTRUCTURING RESERVES (Details)",
"subGroupType": "details",
"uniqueAnchor": null
},
"R4": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:Revenues",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1002000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
"role": "http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"lang": null,
"name": "us-gaap:GrossProfit",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R40": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AmortizationOfIntangibleAssets",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2406402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)",
"role": "http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"shortName": "GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"us-gaap:ScheduleOfGoodwillTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"lang": null,
"name": "us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R41": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2406403 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)",
"role": "http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails",
"shortName": "GOODWILL AND INTANGIBLE ASSETS (Components of identifiable intangible assets) (Details)",
"subGroupType": "details",
"uniqueAnchor": null
},
"R42": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2406404 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details)",
"role": "http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"shortName": "GOODWILL AND INTANGIBLE ASSETS (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"ix:continuation",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"lang": null,
"name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R43": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"us-gaap:ScheduleOfDebtInstrumentsTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2019Q4",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2407401 - Disclosure - DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)",
"role": "http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"shortName": "DEBT (Short-term borrowings and current portion of long-term debt) (Table) (Details)",
"subGroupType": "tables",
"uniqueAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"lang": "en-US",
"name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R44": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2407402 - Disclosure - DEBT (Long-term debt) (Details)",
"role": "http://www.labcorp.com/role/DebtLongTermDebtDetails",
"shortName": "DEBT (Long-term debt) (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R45": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"ix:continuation",
"us-gaap:ScheduleOfShortTermDebtTextBlock",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"first": true,
"lang": null,
"name": "lh:Shorttermdebtissuancecosts",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2407403 - Disclosure - DEBT (Senior Notes) (Details)",
"role": "http://www.labcorp.com/role/DebtSeniorNotesDetails",
"shortName": "DEBT (Senior Notes) (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"ix:continuation",
"us-gaap:ScheduleOfShortTermDebtTextBlock",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"first": true,
"lang": null,
"name": "lh:Shorttermdebtissuancecosts",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R46": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "I2019Q2",
"decimals": "-5",
"first": true,
"lang": null,
"name": "lh:A2019TermLoan",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2407405 - Disclosure - DEBT (Credit Facilities) (Details)",
"role": "http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"shortName": "DEBT (Credit Facilities) (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "I2019Q2",
"decimals": "-5",
"first": true,
"lang": null,
"name": "lh:A2019TermLoan",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R47": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-7",
"first": true,
"lang": null,
"name": "us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2408401 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)",
"role": "http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails",
"shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-7",
"first": true,
"lang": null,
"name": "us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
"reportCount": 1,
"unique": true,
"unitRef": "shares",
"xsiNil": "false"
}
},
"R48": {
"firstAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
"reportCount": 1,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2408402 - Disclosure - PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)",
"role": "http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails",
"shortName": "PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY - Accumulated Other Comprehensive Earnings (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"lang": null,
"name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R49": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "2",
"first": true,
"lang": null,
"name": "us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies",
"reportCount": 1,
"unique": true,
"unitRef": "number",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2409401 - Disclosure - INCOME TAXES (Details)",
"role": "http://www.labcorp.com/role/IncomeTaxesDetails",
"shortName": "INCOME TAXES (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "2",
"first": true,
"lang": null,
"name": "us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies",
"reportCount": 1,
"unique": true,
"unitRef": "number",
"xsiNil": "false"
}
},
"R5": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "lh:NetRestructuringAndOtherSpecialCharges",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1003000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)",
"role": "http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited",
"shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"lang": null,
"name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R50": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "INF",
"first": true,
"lang": null,
"name": "lh:NumberofAdditionalPartiesNotProvidingConsent",
"reportCount": 1,
"unique": true,
"unitRef": "number",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2410401 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
"role": "http://www.labcorp.com/role/CommitmentsAndContingenciesDetails",
"shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "INF",
"first": true,
"lang": null,
"name": "lh:NumberofAdditionalPartiesNotProvidingConsent",
"reportCount": 1,
"unique": true,
"unitRef": "number",
"xsiNil": "false"
}
},
"R51": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "2",
"first": true,
"lang": null,
"name": "lh:NonElectiveContribution",
"reportCount": 1,
"unitRef": "number",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2411401 - Disclosure - PENSION AND POSTRETIREMENT PLANS (Details)",
"role": "http://www.labcorp.com/role/PensionAndPostretirementPlansDetails",
"shortName": "PENSION AND POSTRETIREMENT PLANS (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"lang": "en-US",
"name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R52": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "2",
"first": true,
"lang": null,
"name": "lh:NonElectiveContribution",
"reportCount": 1,
"unitRef": "number",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2411402 - Disclosure - PENSION AND POSTRETIREMENT PLANS Defined Contribution Plans (Details)",
"role": "http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"shortName": "PENSION AND POSTRETIREMENT PLANS Defined Contribution Plans (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "2",
"lang": null,
"name": "lh:DiscretionaryContributionPercentageMinimum",
"reportCount": 1,
"unique": true,
"unitRef": "number",
"xsiNil": "false"
}
},
"R53": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "0",
"first": true,
"lang": null,
"name": "lh:NumberofMeasurementFundsAvailableForParticipantElection",
"reportCount": 1,
"unique": true,
"unitRef": "number",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2412402 - Disclosure - FAIR VALUE MEASUREMENTS (Details)",
"role": "http://www.labcorp.com/role/FairValueMeasurementsDetails",
"shortName": "FAIR VALUE MEASUREMENTS (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "0",
"first": true,
"lang": null,
"name": "lh:NumberofMeasurementFundsAvailableForParticipantElection",
"reportCount": 1,
"unique": true,
"unitRef": "number",
"xsiNil": "false"
}
},
"R54": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2413402 - Disclosure - DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details)",
"role": "http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails",
"shortName": "DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R55": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"ix:continuation",
"us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "lh:DecreaseinCapitalExpendituresIncurredbutnotyetPaid",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2414402 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details)",
"role": "http://www.labcorp.com/role/SupplementalCashFlowInformationDetails",
"shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"ix:continuation",
"us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "lh:DecreaseinCapitalExpendituresIncurredbutnotyetPaid",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R56": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:Revenues",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2415402 - Disclosure - BUSINESS ACQUISITIONS (Details)",
"role": "http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"shortName": "BUSINESS ACQUISITIONS (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "I2019Q2",
"decimals": "-5",
"lang": null,
"name": "lh:Totalacquisitionconsiderationcashstocknotesetc.",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R57": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2415403 - Disclosure - BUSINESS ACQUISITIONS Business Acquisitions in the Aggregate (Details)",
"role": "http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"shortName": "BUSINESS ACQUISITIONS Business Acquisitions in the Aggregate (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R58": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2415404 - Disclosure - BUSINESS ACQUISITIONS DISPOSITIONS (Details)",
"role": "http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"shortName": "BUSINESS ACQUISITIONS DISPOSITIONS (Details)",
"subGroupType": "details",
"uniqueAnchor": null
},
"R59": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"us-gaap:DisaggregationOfRevenueTableTextBlock",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "2",
"first": true,
"lang": null,
"name": "lh:PercentofRevenueContributed",
"reportCount": 1,
"unitRef": "number",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2417401 - Disclosure - BUSINESS SEGMENT INFORMATION Business Segment Information (Details)",
"role": "http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"shortName": "BUSINESS SEGMENT INFORMATION Business Segment Information (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"ix:continuation",
"us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"lang": null,
"name": "lh:Intercompanyrevenueelimination",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R6": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2018Q4",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:StockholdersEquity",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1004000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)",
"role": "http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited",
"shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
"decimals": "-5",
"lang": null,
"name": "us-gaap:StockholdersEquity",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R60": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"ix:continuation",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2418403 - Disclosure - REVENUE Disaggregated Revenue Table (Details)",
"role": "http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"shortName": "REVENUE Disaggregated Revenue Table (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"ix:continuation",
"ix:continuation",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"lang": null,
"name": "lh:UnbilledServicesAllowanceforCreditLoss",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R61": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "D2020Q1FundsAppropriated_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember",
"decimals": "-5",
"first": true,
"lang": null,
"name": "lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2419402 - Disclosure - Subsequent Event (Details)",
"role": "http://www.labcorp.com/role/SubsequentEventDetails",
"shortName": "Subsequent Event (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "D2020Q1FundsAppropriated_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember",
"decimals": "-5",
"first": true,
"lang": null,
"name": "lh:CashPaymentReceivedAppropriatedbyU.S.CongressCovid19",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R62": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FI2020Q1",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:OperatingLeaseLiabilityCurrent",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2420402 - Disclosure - Leases (Details)",
"role": "http://www.labcorp.com/role/LeasesDetails",
"shortName": "Leases (Details)",
"subGroupType": "details",
"uniqueAnchor": null
},
"R7": {
"firstAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"first": true,
"lang": null,
"name": "us-gaap:ProfitLoss",
"reportCount": 1,
"unitRef": "usd",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "1005000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
"role": "http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"span",
"div",
"td",
"tr",
"table",
"div",
"div",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": "-5",
"lang": null,
"name": "lh:DepreciationAndAmortizationOfLeasedAssets",
"reportCount": 1,
"unique": true,
"unitRef": "usd",
"xsiNil": "false"
}
},
"R8": {
"firstAnchor": {
"ancestors": [
"us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2101100 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION",
"role": "http://www.labcorp.com/role/BasisOfFinancialStatementPresentation",
"shortName": "BASIS OF FINANCIAL STATEMENT PRESENTATION",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R9": {
"firstAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:EarningsPerShareTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "2102100 - Disclosure - EARNINGS PER SHARE",
"role": "http://www.labcorp.com/role/EarningsPerShare",
"shortName": "EARNINGS PER SHARE",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"td",
"tr",
"table",
"div",
"body",
"html"
],
"baseRef": "lh202010-qq1projectfile.htm",
"contextRef": "FD2020Q1QTD",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:EarningsPerShareTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
}
},
"segmentCount": 83,
"tag": {
"country_CA": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "CANADA",
"terseLabel": "CANADA"
}
}
},
"localname": "CA",
"nsuri": "http://xbrl.sec.gov/country/2017-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"country_CH": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "SWITZERLAND",
"terseLabel": "SWITZERLAND"
}
}
},
"localname": "CH",
"nsuri": "http://xbrl.sec.gov/country/2017-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"country_GB": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "UNITED KINGDOM",
"terseLabel": "UNITED KINGDOM"
}
}
},
"localname": "GB",
"nsuri": "http://xbrl.sec.gov/country/2017-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"country_US": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "UNITED STATES",
"terseLabel": "UNITED STATES"
}
}
},
"localname": "US",
"nsuri": "http://xbrl.sec.gov/country/2017-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"dei_AmendmentFlag": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
"label": "Amendment Flag",
"terseLabel": "Amendment Flag"
}
}
},
"localname": "AmendmentFlag",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_CityAreaCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Area code of city",
"label": "City Area Code",
"terseLabel": "City Area Code"
}
}
},
"localname": "CityAreaCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_CoverAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cover page.",
"label": "Cover [Abstract]"
}
}
},
"localname": "CoverAbstract",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"xbrltype": "stringItemType"
},
"dei_CurrentFiscalYearEndDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "End date of current fiscal year in the format --MM-DD.",
"label": "Current Fiscal Year End Date",
"terseLabel": "Current Fiscal Year End Date"
}
}
},
"localname": "CurrentFiscalYearEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "gMonthDayItemType"
},
"dei_DocumentDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.",
"label": "Document [Domain]",
"terseLabel": "Document [Domain]"
}
}
},
"localname": "DocumentDomain",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "domainItemType"
},
"dei_DocumentFiscalPeriodFocus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
"label": "Document Fiscal Period Focus",
"terseLabel": "Document Fiscal Period Focus"
}
}
},
"localname": "DocumentFiscalPeriodFocus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "fiscalPeriodItemType"
},
"dei_DocumentFiscalYearFocus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
"label": "Document Fiscal Year Focus",
"terseLabel": "Document Fiscal Year Focus"
}
}
},
"localname": "DocumentFiscalYearFocus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "gYearItemType"
},
"dei_DocumentInformationDocumentAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
"label": "Document Information, Document [Axis]",
"terseLabel": "Document Information, Document [Axis]"
}
}
},
"localname": "DocumentInformationDocumentAxis",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "stringItemType"
},
"dei_DocumentInformationLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Document Information [Line Items]",
"terseLabel": "Document Information [Line Items]"
}
}
},
"localname": "DocumentInformationLineItems",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "stringItemType"
},
"dei_DocumentInformationTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
"label": "Document Information [Table]",
"terseLabel": "Document Information [Table]"
}
}
},
"localname": "DocumentInformationTable",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "stringItemType"
},
"dei_DocumentPeriodEndDate": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
"label": "Document Period End Date",
"terseLabel": "Document Period End Date"
}
}
},
"localname": "DocumentPeriodEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "dateItemType"
},
"dei_DocumentQuarterlyReport": {
"auth_ref": [
"r423"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true only for a form used as an quarterly report.",
"label": "Document Quarterly Report",
"terseLabel": "Document Quarterly Report"
}
}
},
"localname": "DocumentQuarterlyReport",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentTransitionReport": {
"auth_ref": [
"r424"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true only for a form used as a transition report.",
"label": "Document Transition Report",
"terseLabel": "Document Transition Report"
}
}
},
"localname": "DocumentTransitionReport",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentType": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
"label": "Document Type",
"terseLabel": "Document Type"
}
}
},
"localname": "DocumentType",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "submissionTypeItemType"
},
"dei_EntityAddressAddressLine1": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Address Line 1 such as Attn, Building Name, Street Name",
"label": "Entity Address, Address Line One",
"terseLabel": "Entity Address, Address Line One"
}
}
},
"localname": "EntityAddressAddressLine1",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCityOrTown": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the City or Town",
"label": "Entity Address, City or Town",
"terseLabel": "Entity Address, City or Town"
}
}
},
"localname": "EntityAddressCityOrTown",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressPostalZipCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Code for the postal or zip code",
"label": "Entity Address, Postal Zip Code",
"terseLabel": "Entity Address, Postal Zip Code"
}
}
},
"localname": "EntityAddressPostalZipCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressStateOrProvince": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the state or province.",
"label": "Entity Address, State or Province",
"terseLabel": "Entity Address, State or Province"
}
}
},
"localname": "EntityAddressStateOrProvince",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "stateOrProvinceItemType"
},
"dei_EntityCentralIndexKey": {
"auth_ref": [
"r425"
],
"lang": {
"en-US": {
"role": {
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
"label": "Entity Central Index Key",
"terseLabel": "Entity Central Index Key"
}
}
},
"localname": "EntityCentralIndexKey",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "centralIndexKeyItemType"
},
"dei_EntityCommonStockSharesOutstanding": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
"label": "Entity Common Stock, Shares Outstanding",
"terseLabel": "Entity Common Stock, Shares Outstanding"
}
}
},
"localname": "EntityCommonStockSharesOutstanding",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "sharesItemType"
},
"dei_EntityCurrentReportingStatus": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Current Reporting Status",
"terseLabel": "Entity Current Reporting Status"
}
}
},
"localname": "EntityCurrentReportingStatus",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
"label": "Entity [Domain]",
"terseLabel": "Entity [Domain]"
}
}
},
"localname": "EntityDomain",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails",
"http://www.labcorp.com/role/NoncontrollingInterestPutsDetails"
],
"xbrltype": "domainItemType"
},
"dei_EntityEmergingGrowthCompany": {
"auth_ref": [
"r425"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate if registrant meets the emerging growth company criteria.",
"label": "Entity Emerging Growth Company",
"terseLabel": "Entity Emerging Growth Company"
}
}
},
"localname": "EntityEmergingGrowthCompany",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_EntityFileNumber": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
"label": "Entity File Number",
"terseLabel": "Entity File Number"
}
}
},
"localname": "EntityFileNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "fileNumberItemType"
},
"dei_EntityFilerCategory": {
"auth_ref": [
"r425"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Filer Category",
"terseLabel": "Entity Filer Category"
}
}
},
"localname": "EntityFilerCategory",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "filerCategoryItemType"
},
"dei_EntityIncorporationStateCountryCode": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Two-character EDGAR code representing the state or country of incorporation.",
"label": "Entity Incorporation, State or Country Code",
"terseLabel": "Entity Incorporation, State or Country Code"
}
}
},
"localname": "EntityIncorporationStateCountryCode",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "edgarStateCountryItemType"
},
"dei_EntityInteractiveDataCurrent": {
"auth_ref": [
"r426"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
"label": "Entity Interactive Data Current",
"terseLabel": "Entity Interactive Data Current"
}
}
},
"localname": "EntityInteractiveDataCurrent",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityRegistrantName": {
"auth_ref": [
"r425"
],
"lang": {
"en-US": {
"role": {
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
"label": "Entity Registrant Name",
"terseLabel": "Entity Registrant Name"
}
}
},
"localname": "EntityRegistrantName",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityShellCompany": {
"auth_ref": [
"r425"
],
"lang": {
"en-US": {
"role": {
"documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
"label": "Entity Shell Company",
"terseLabel": "Entity Shell Company"
}
}
},
"localname": "EntityShellCompany",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_EntitySmallBusiness": {
"auth_ref": [
"r425"
],
"lang": {
"en-US": {
"role": {
"documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
"label": "Entity Small Business",
"terseLabel": "Entity Small Business"
}
}
},
"localname": "EntitySmallBusiness",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "booleanItemType"
},
"dei_EntityTaxIdentificationNumber": {
"auth_ref": [
"r425"
],
"lang": {
"en-US": {
"role": {
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
"label": "Entity Tax Identification Number",
"terseLabel": "Entity Tax Identification Number"
}
}
},
"localname": "EntityTaxIdentificationNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "employerIdItemType"
},
"dei_LegalEntityAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The set of legal entities associated with a report.",
"label": "Legal Entity [Axis]",
"terseLabel": "Legal Entity [Axis]"
}
}
},
"localname": "LegalEntityAxis",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails",
"http://www.labcorp.com/role/NoncontrollingInterestPutsDetails"
],
"xbrltype": "stringItemType"
},
"dei_LocalPhoneNumber": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Local phone number for entity.",
"label": "Local Phone Number",
"terseLabel": "Local Phone Number"
}
}
},
"localname": "LocalPhoneNumber",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "normalizedStringItemType"
},
"dei_Security12bTitle": {
"auth_ref": [
"r421"
],
"lang": {
"en-US": {
"role": {
"documentation": "Title of a 12(b) registered security.",
"label": "Title of 12(b) Security",
"terseLabel": "Title of 12(b) Security"
}
}
},
"localname": "Security12bTitle",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "securityTitleItemType"
},
"dei_SecurityExchangeName": {
"auth_ref": [
"r422"
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of the Exchange on which a security is registered.",
"label": "Security Exchange Name",
"terseLabel": "Security Exchange Name"
}
}
},
"localname": "SecurityExchangeName",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "edgarExchangeCodeItemType"
},
"dei_TradingSymbol": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Trading symbol of an instrument as listed on an exchange.",
"label": "Trading Symbol",
"terseLabel": "Trading Symbol"
}
}
},
"localname": "TradingSymbol",
"nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CoverPage"
],
"xbrltype": "tradingSymbolItemType"
},
"lh_A2.30seniornotesdue2024": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "2.30% senior notes due 2024",
"label": "2.30% senior notes due 2024",
"terseLabel": "2.30% senior notes due 2024"
}
}
},
"localname": "A2.30seniornotesdue2024",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_A2.95seniornotesdue2029": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "2.95% senior notes due 2029",
"label": "2.95% senior notes due 2029",
"terseLabel": "2.95% senior notes due 2029"
}
}
},
"localname": "A2.95seniornotesdue2029",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_A2019TermLoan": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "2019 Term Loan",
"label": "2019 Term Loan",
"terseLabel": "2019 Term Loan"
}
}
},
"localname": "A2019TermLoan",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_A2019TermLoanMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "2019 Term Loan [Member]",
"label": "2019 Term Loan [Member]",
"terseLabel": "2019 Term Loan [Member]"
}
}
},
"localname": "A2019TermLoanMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "domainItemType"
},
"lh_A4.625Seniornotesdue2020": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "4.625% Senior notes due 2020",
"label": "4.625% Senior notes due 2020",
"terseLabel": "4.625% Senior notes due 2020"
}
}
},
"localname": "A4.625Seniornotesdue2020",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_AccumulatedOtherComprehensiveEarningsRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated Other Comprehensive Earnings [Roll Forward]",
"label": "Accumulated Other Comprehensive Earnings [Roll Forward]",
"terseLabel": "Accumulated Other Comprehensive Earnings [Roll Forward]"
}
}
},
"localname": "AccumulatedOtherComprehensiveEarningsRollForward",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "stringItemType"
},
"lh_AllowanceforCreditLoss": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Allowance for Credit Loss",
"label": "Allowance for Credit Loss",
"terseLabel": "Allowance for Credit Loss"
}
}
},
"localname": "AllowanceforCreditLoss",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_AllowanceforCreditLossWriteOff": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Allowance for Credit Loss, Write Off",
"label": "Allowance for Credit Loss, Write Off",
"terseLabel": "Allowance for Credit Loss, Write Off"
}
}
},
"localname": "AllowanceforCreditLossWriteOff",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_BiopharmaceuticalandmedicaldevicecompaniesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Biopharmaceutical and medical device companies [Member]",
"label": "Biopharmaceutical and medical device companies [Member]",
"terseLabel": "Biopharmaceutical and medical device companies [Member]"
}
}
},
"localname": "BiopharmaceuticalandmedicaldevicecompaniesMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"lh_BusinessCombinationPurchasePriceAllocationLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "[Line Items] for Business Combination Purchase Price Allocation [Table]",
"label": "Business Combination Purchase Price Allocation [Line Items]",
"terseLabel": "Business Combination Purchase Price Allocation [Line Items]"
}
}
},
"localname": "BusinessCombinationPurchasePriceAllocationLineItems",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "stringItemType"
},
"lh_BusinessCombinationPurchasePriceAllocationTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Business Combination Purchase Price Allocation [Table]",
"label": "Business Combination Purchase Price Allocation [Table]",
"terseLabel": "Business Combination Purchase Price Allocation [Table]"
}
}
},
"localname": "BusinessCombinationPurchasePriceAllocationTable",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "stringItemType"
},
"lh_CashFlowLocationAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cash Flow Location [Axis]",
"label": "Cash Flow Location [Axis]",
"terseLabel": "Cash Flow Location [Axis]"
}
}
},
"localname": "CashFlowLocationAxis",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails"
],
"xbrltype": "stringItemType"
},
"lh_CashFlowLocationDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "[Domain] for Cash Flow Location [Axis]",
"label": "Cash Flow Location [Domain]",
"terseLabel": "Cash Flow Location [Domain]"
}
}
},
"localname": "CashFlowLocationDomain",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails"
],
"xbrltype": "domainItemType"
},
"lh_CashPaidDuringPeriodForAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "",
"label": "Cash Paid During Period For [Abstract]",
"terseLabel": "Cash paid during period for:"
}
}
},
"localname": "CashPaidDuringPeriodForAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "stringItemType"
},
"lh_CashPaymentReceivedAppropriatedbyU.S.CongressCovid19": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Cash Payment Received Appropriated by U.S. Congress Covid-19",
"label": "Cash Payment Received Appropriated by U.S. Congress Covid-19",
"terseLabel": "Cash Payment Received Appropriated by U.S. Congress Covid-19"
}
}
},
"localname": "CashPaymentReceivedAppropriatedbyU.S.CongressCovid19",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule is used to show the changes in common shares issued and held in treasury by the entity.",
"label": "Changes In Common Shares Issued And Held In Treasury [Table Text Block]",
"terseLabel": "Changes in common shares issued and held in treasury"
}
}
},
"localname": "ChangesInCommonSharesIssuedAndHeldInTreasuryTableTextBlock",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquity"
],
"xbrltype": "textBlockItemType"
},
"lh_ClientMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Client [Member]",
"label": "Client [Member]",
"terseLabel": "Client [Member]"
}
}
},
"localname": "ClientMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"lh_CommonSharesHeldInTreasuryRollforwardAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "",
"label": "Common Shares Held In Treasury Rollforward [Abstract]",
"terseLabel": "Rollforward of common shares held in treasury"
}
}
},
"localname": "CommonSharesHeldInTreasuryRollforwardAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"lh_CommonSharesIssuedRollforwardAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "",
"label": "Common Shares Issued Rollforward [Abstract]",
"terseLabel": "Rollforward of common shares issued"
}
}
},
"localname": "CommonSharesIssuedRollforwardAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"lh_CommonSharesOutstandingRollforwardAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "",
"label": "Common Shares Outstanding Rollforward [Abstract]",
"terseLabel": "Common Shares Outstanding Rollforward [Abstract]"
}
}
},
"localname": "CommonSharesOutstandingRollforwardAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"lh_CommonStockRepurchaseAuthorizationOutstanding": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The dollar amount of share (common shares) repurchase authorization approved by the Board of Directors which remains available to the Company.",
"label": "Common Stock Repurchase Authorization Outstanding",
"periodEndLabel": "Outstanding common stock repurchase authorization, ending balance",
"periodStartLabel": "Outstanding common stock repurchase authorization, beginning balance"
}
}
},
"localname": "CommonStockRepurchaseAuthorizationOutstanding",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of common shares issued during the period as a result of an employee stock purchase plan and/or stock option plan.",
"label": "Commons Stock Issued During Period Shares Employee Stock Plans",
"terseLabel": "Commons Stock Issued During Period Shares Employee Stock Plans"
}
}
},
"localname": "CommonsStockIssuedDuringPeriodSharesEmployeeStockPlans",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"lh_Commonstockrepurchaseaveragepurchasepricepershare": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Common stock repurchase average purchase price per share",
"label": "Common stock repurchase average purchase price per share",
"terseLabel": "Common stock repurchase average purchase price per share"
}
}
},
"localname": "Commonstockrepurchaseaveragepurchasepricepershare",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"lh_Contingentconsiderationadjustment": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 15.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Contingent consideration adjustment",
"label": "Contingent consideration adjustment",
"negatedTerseLabel": "Contingent consideration adjustment",
"terseLabel": "Contingent consideration adjustment"
}
}
},
"localname": "Contingentconsiderationadjustment",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_ConversionOfZeroCouponConvertibleDebt": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Value of stock issued during the period upon the conversion of convertible securities (zero-coupon subordinated notes) and/or reversal of deferred tax liability to reflect the tax benefit realized upon issuance of the stock.",
"label": "Conversion of zero-coupon convertible debt",
"terseLabel": "Conversion of zero-coupon convertible debt"
}
}
},
"localname": "ConversionOfZeroCouponConvertibleDebt",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited",
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_CostMethodInvestmentsMaximumOwnershipPercentage": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "This element represents the maximum ownership percentage of cost-method investments held by the Company. Generally, such investments do not have readily determinable fair values and are not required to be accounted for by the equity method. The carrying amount of such securities equates to cost, adjusted for other-than-temporary impairment.",
"label": "Cost Method Investments Maximum Ownership Percentage",
"terseLabel": "Ownership percentage below which investments are generally accounted for on the cost method (in thousandths)"
}
}
},
"localname": "CostMethodInvestmentsMaximumOwnershipPercentage",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails"
],
"xbrltype": "percentItemType"
},
"lh_CovanceDrugDevelopmentMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Covance Drug Development [Member]",
"label": "Covance Drug Development [Member]",
"terseLabel": "Covance Drug Development [Member]"
}
}
},
"localname": "CovanceDrugDevelopmentMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"lh_CovanceMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Covance [Member]",
"label": "Covance [Member]",
"terseLabel": "Covance [Member]"
}
}
},
"localname": "CovanceMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails"
],
"xbrltype": "domainItemType"
},
"lh_CreditFacilityMaximumLettersofCredit": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Credit Facility, Maximum Letters of Credit",
"label": "Credit Facility, Maximum Letters of Credit",
"terseLabel": "Credit Facility, Maximum Letters of Credit"
}
}
},
"localname": "CreditFacilityMaximumLettersofCredit",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_CreditFacilityMaximumSwingLineBorrowings": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Credit Facility, Maximum Swing Line Borrowings",
"label": "Credit Facility, Maximum Swing Line Borrowings",
"terseLabel": "Credit Facility, Maximum Swing Line Borrowings"
}
}
},
"localname": "CreditFacilityMaximumSwingLineBorrowings",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_CreditFacilityOptiontoIncrease": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Credit Facility Option to Increase",
"label": "Credit Facility Option to Increase",
"terseLabel": "Credit Facility Option to Increase"
}
}
},
"localname": "CreditFacilityOptiontoIncrease",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_CreditLossExpenseReversal": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Credit Loss Expense (Reversal)",
"label": "Credit Loss Expense (Reversal)",
"terseLabel": "Credit Loss Expense (Reversal)"
}
}
},
"localname": "CreditLossExpenseReversal",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_Crosscurrencyswapmaturing2022Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cross currency swap maturing 2022 [Member]",
"label": "Cross currency swap maturing 2022 [Member]",
"terseLabel": "Cross currency swap maturing 2022 [Member]"
}
}
},
"localname": "Crosscurrencyswapmaturing2022Member",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "domainItemType"
},
"lh_Crosscurrencyswapmaturing2025Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Cross currency swap maturing 2025 [Member]",
"label": "Cross currency swap maturing 2025 [Member]",
"terseLabel": "Senior notes due 2025 [Member] [Member]"
}
}
},
"localname": "Crosscurrencyswapmaturing2025Member",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "domainItemType"
},
"lh_CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings",
"label": "Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings",
"terseLabel": "Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings"
}
}
},
"localname": "CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_DamagesPerViolation": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Damages Per Violation",
"label": "Damages Per Violation",
"terseLabel": "Damages Per Violation"
}
}
},
"localname": "DamagesPerViolation",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_DebttoEBITDALeverageRatioNextThreeQuarters": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Debt to EBITDA (Leverage) Ratio Next Three Quarters",
"label": "Debt to EBITDA (Leverage) Ratio Next Three Quarters",
"terseLabel": "Debt to EBITDA (Leverage) Ratio Next Three Quarters"
}
}
},
"localname": "DebttoEBITDALeverageRatioNextThreeQuarters",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "decimalItemType"
},
"lh_DebttoEBITDALeverageRatioQuarterEnding1YearFromPresent": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Debt to EBITDA (Leverage) Ratio Quarter Ending 1 Year From Present Quarter End",
"label": "Debt to EBITDA (Leverage) Ratio Quarter Ending 1 Year From Present",
"terseLabel": "Debt to EBITDA (Leverage) Ratio Quarter Ending 1 Year From Present"
}
}
},
"localname": "DebttoEBITDALeverageRatioQuarterEnding1YearFromPresent",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "decimalItemType"
},
"lh_DecreaseinCapitalExpendituresIncurredbutnotyetPaid": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Decrease in Capital Expenditures Incurred but not yet Paid",
"label": "Decrease in Capital Expenditures Incurred but not yet Paid",
"negatedTerseLabel": "Decrease in Capital Expenditures Incurred but not yet Paid"
}
}
},
"localname": "DecreaseinCapitalExpendituresIncurredbutnotyetPaid",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_DeferredIncomeTaxesAndOtherTaxLiabilities": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax, combined with the noncurrent portion of the amount recognized for uncertain tax positions as of the balance sheet date. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.",
"label": "Deferred income taxes and other tax liabilities",
"terseLabel": "Deferred income taxes and other tax liabilities"
}
}
},
"localname": "DeferredIncomeTaxesAndOtherTaxLiabilities",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"lh_DefinedContributionPlanTotalExpense": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Defined Contribution Plan Total Expense",
"label": "Defined Contribution Plan Total Expense",
"terseLabel": "Defined Contribution Plan Total Expense"
}
}
},
"localname": "DefinedContributionPlanTotalExpense",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_DepreciationAndAmortizationOfLeasedAssets": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of depreciation recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Also, may include amortization charged against earnings for the periodic recognition of capitalized leases.",
"label": "Depreciation And Amortization Of Leased Assets",
"terseLabel": "Depreciation And Amortization Of Leased Assets"
}
}
},
"localname": "DepreciationAndAmortizationOfLeasedAssets",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"lh_DisaggregatedRevenueTableAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disaggregated Revenue Table [Abstract]",
"label": "Disaggregated Revenue Table [Abstract]"
}
}
},
"localname": "DisaggregatedRevenueTableAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"xbrltype": "stringItemType"
},
"lh_DiscretionaryContributionPercentageMaximum": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The maximum discretionary contribution % by the company for eligible employees based on service.",
"label": "Discretionary Contribution Percentage Maximum",
"terseLabel": "Discretionary Contribution Percentage Maximum"
}
}
},
"localname": "DiscretionaryContributionPercentageMaximum",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "percentItemType"
},
"lh_DiscretionaryContributionPercentageMinimum": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Discretionary contribution percentage by the company for eligible employees based on service, range minimum.",
"label": "Discretionary Contribution Percentage Minimum",
"terseLabel": "Discretionary Contribution Percentage Minimum"
}
}
},
"localname": "DiscretionaryContributionPercentageMinimum",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails"
],
"xbrltype": "percentItemType"
},
"lh_EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of any reversal and other adjustment made during the period to the amount of a previously accrued liability for employee severance benefits related restructuring costs, excluding adjustments for costs incurred during the period, costs settled during the period, and foreign currency translation adjustments.",
"label": "Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment",
"negatedTerseLabel": "Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment",
"terseLabel": "Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment"
}
}
},
"localname": "EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_EnvigoMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Envigo [Member]",
"label": "Envigo [Member]",
"terseLabel": "Envigo [Member]"
}
}
},
"localname": "EnvigoMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"lh_EquityMethodIncomeLossNetDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Equity Method Income (Loss), Net [Domain]",
"label": "Equity Method Income (Loss), Net [Domain]",
"terseLabel": "Equity Method Income (Loss), Net [Domain]"
}
}
},
"localname": "EquityMethodIncomeLossNetDomain",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails"
],
"xbrltype": "domainItemType"
},
"lh_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability",
"label": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability",
"terseLabel": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability"
}
}
},
"localname": "FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "This element represents a certain statement of financial position liability caption which represents a class of liabilities, or which may include an individual liability, measured at fair value on a recurring basis.",
"label": "Fair Value Liabilities Measured On Recurring Basis Noncontrolling Interest Puts",
"terseLabel": "Noncontrolling interest puts"
}
}
},
"localname": "FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_Impairmentoffloatingratenotereceivable": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "impairment of floating rate note receivable",
"label": "impairment of floating rate note receivable",
"terseLabel": "impairment of floating rate note receivable"
}
}
},
"localname": "Impairmentoffloatingratenotereceivable",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_IncomeAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "",
"label": "Income [Abstract]",
"terseLabel": "Income [Abstract]"
}
}
},
"localname": "IncomeAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/EarningsPerShareReconciliationOfBasicEarningsPerShareToDilutedEarningsPerShareDetails"
],
"xbrltype": "stringItemType"
},
"lh_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of operating profit and nonoperating income (expense) before income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest.",
"label": "Income Loss from Continuing Operations Before Income Taxes and Minority Interest",
"terseLabel": "Provision for income taxes"
}
}
},
"localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_ProfitLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest",
"label": "Income (Loss) from Continuing Operations Before Income Taxes and Noncontrolling Interest",
"terseLabel": "Earnings before income taxes",
"totalLabel": "Earnings before income taxes"
}
}
},
"localname": "IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"lh_IncreaseDecreaseinOperatingIncomeLoss": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Increase (decrease) in operating profit due to favorable/unfavorable pricing adjustments",
"label": "Increase Decrease in Operating Income Loss",
"terseLabel": "Increase Decrease in Operating Income Loss"
}
}
},
"localname": "IncreaseDecreaseinOperatingIncomeLoss",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_IncreaseDecreaseinUnbilledContractReceivable": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 9.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Increase (Decrease) in Unbilled Contract Receivable",
"label": "Increase (Decrease) in Unbilled Contract Receivable",
"terseLabel": "Increase (Decrease) in Unbilled Contract Receivable"
}
}
},
"localname": "IncreaseDecreaseinUnbilledContractReceivable",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"lh_Intercompanyrevenueelimination": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Intercompany revenue elimination",
"label": "Intercompany revenue elimination",
"negatedTerseLabel": "Intercompany revenue elimination"
}
}
},
"localname": "Intercompanyrevenueelimination",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_InterestPaidInCash": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of cash paid during the current period for interest owed on money borrowed",
"label": "Interest Paid In Cash",
"terseLabel": "Interest"
}
}
},
"localname": "InterestPaidInCash",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_Issuanceofcommonstockunderemployeeplans": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate change in value for stock issued in period under ESPP combined with the value of stock issued as a result of option exercises.",
"label": "Issuance of common stock under employee plans",
"negatedTerseLabel": "Issuance of common stock under employee stock plans"
}
}
},
"localname": "Issuanceofcommonstockunderemployeeplans",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited"
],
"xbrltype": "monetaryItemType"
},
"lh_LabCorpDiagnosticsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "LabCorp Diagnostics [Member]",
"label": "LabCorp Diagnostics [Member]",
"terseLabel": "LabCorp Diagnostics [Member]"
}
}
},
"localname": "LabCorpDiagnosticsMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"lh_LongTermContractsDurationMaximum": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Long Term Contracts Duration Maximum",
"label": "Long Term Contracts Duration Maximum",
"terseLabel": "Long Term Contracts Duration Maximum"
}
}
},
"localname": "LongTermContractsDurationMaximum",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "durationItemType"
},
"lh_LongTermContractsDurationMinimum": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Long Term Contracts Duration Minimum",
"label": "Long Term Contracts Duration Minimum",
"terseLabel": "Long Term Contracts Duration Minimum"
}
}
},
"localname": "LongTermContractsDurationMinimum",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "durationItemType"
},
"lh_Longtermdebtissuancecosts": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Long term debt issuance costs",
"label": "Long term debt issuance costs",
"terseLabel": "Long term debt issuance costs"
}
}
},
"localname": "Longtermdebtissuancecosts",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_MedicareandMedicaidMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Medicare and Medicaid [Member]",
"label": "Medicare and Medicaid [Member]",
"terseLabel": "Medicare and Medicaid [Member]"
}
}
},
"localname": "MedicareandMedicaidMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"lh_NetDefinedBenefitPlanAmortizationAndDeferral": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails": {
"order": 4.0,
"parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Net Defined Benefit Plan Amortization And Deferral",
"label": "Net Defined Benefit Plan Amortization And Deferral",
"terseLabel": "Net amortization and deferral"
}
}
},
"localname": "NetDefinedBenefitPlanAmortizationAndDeferral",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_NetProceedsFromIssuanceOfStockToEmployees": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow associated with the amount received from holders exercising their stock options and employees related to shares purchased under the employee stock purchase plan.",
"label": "Net proceeds from issuance of stock to employees",
"terseLabel": "Net proceeds from issuance of stock to employees"
}
}
},
"localname": "NetProceedsFromIssuanceOfStockToEmployees",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"lh_NetRestructuringAndOtherSpecialCharges": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program planned and controlled by management, and materially changes either the scope or manner of conduct of a business undertaken. Also, may include reversals and other adjustments to accrued liabilities and special charges, if any, for asset abandonment, uncollectible balances, etc.",
"label": "Net restructuring and other special charges",
"terseLabel": "Net restructuring and other special charges"
}
}
},
"localname": "NetRestructuringAndOtherSpecialCharges",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"lh_NetRestructuringCharges": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount charged against earnings in the period for incurred and estimated costs, excluding asset retirement obligations, associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management, and changes either scope of business by an entity, or manner business is conducted. May include amount of reversals and other adjustments during the period to amounts of previously accrued liabilities for specified types of restructuring costs.",
"label": "Net Restructuring Charges",
"terseLabel": "Net restructuring charges"
}
}
},
"localname": "NetRestructuringCharges",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_NonElectiveContribution": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The minimum non-elective contribution % by the company to all employees eligible for the defined contribution retirement plan. Contributions are concurrent with each payroll period and are non-forfeitable and vest immediately.",
"label": "Non Elective Contribution",
"terseLabel": "Minimum non-elective contribution (NEC) % for the 401(K) plan (in hundredths)",
"verboseLabel": "Non Elective Contribution"
}
}
},
"localname": "NonElectiveContribution",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "percentItemType"
},
"lh_NoncontrollingInterestMezzanineEquity": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Represents contractual value of a noncontrolling interest put (includes underlying noncontrolling interest). In February 2010, the Company completed a transaction to sell the partnership units acquired from the previous noncontrolling interest holder to a new Canadian partner. As a result of this transaction, the Company recorded a component of noncontrolling interest in liabilities and a component in mezzanine equity. This item represents the mezzanine equity component.",
"label": "Noncontrolling Interest Mezzanine Equity",
"terseLabel": "Common stock, 92.8 and 93.5 shares outstanding at March 31, 2013 and December 31, 2012, respectively"
}
}
},
"localname": "NoncontrollingInterestMezzanineEquity",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"lh_NoncontrollingInterestPutsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Noncontrolling Interest Puts [Abstract]",
"label": "Noncontrolling Interest Puts [Abstract]"
}
}
},
"localname": "NoncontrollingInterestPutsAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"xbrltype": "stringItemType"
},
"lh_NoteReceivableAllowanceforCreditLoss": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Note Receivable, Allowance for Credit Loss",
"label": "Note Receivable, Allowance for Credit Loss",
"terseLabel": "Note Receivable, Allowance for Credit Loss"
}
}
},
"localname": "NoteReceivableAllowanceforCreditLoss",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_NoteReceivableCreditLossExpenseReversal": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Note Receivable, Credit Loss Expense (Reversal)",
"label": "Note Receivable, Credit Loss Expense (Reversal)",
"terseLabel": "Note Receivable, Credit Loss Expense (Reversal)"
}
}
},
"localname": "NoteReceivableCreditLossExpenseReversal",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Novel Coranvirus (Covid-19) Financial Statement Impact [Policy Text Block]",
"label": "Novel Coranvirus (Covid-19) Financial Statement Impact [Policy Text Block]",
"terseLabel": "Novel Coranvirus (Covid-19) Financial Statement Impact [Policy Text Block]"
}
}
},
"localname": "NovelCoranvirusCovid19FinancialStatementImpactPolicyTextBlock",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationNovelCoronavirusCovid19FinancialStatementImpactPolicies"
],
"xbrltype": "textBlockItemType"
},
"lh_NumberofAdditionalPartiesNotProvidingConsent": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of Additional Parties Not Providing Consent",
"label": "Number of Additional Parties Not Providing Consent",
"terseLabel": "Number of Additional Parties Not Providing Consent"
}
}
},
"localname": "NumberofAdditionalPartiesNotProvidingConsent",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails"
],
"xbrltype": "pureItemType"
},
"lh_NumberofMeasurementFundsAvailableForParticipantElection": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of Measurement Funds Available For Participant Election",
"label": "Number of Measurement Funds Available For Participant Election",
"terseLabel": "Number of Measurement Funds Available For Participant Election"
}
}
},
"localname": "NumberofMeasurementFundsAvailableForParticipantElection",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "pureItemType"
},
"lh_OtherFinancingCashFlows": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 6.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Other Financing Cash Flows",
"label": "Other Financing Cash Flows",
"negatedTerseLabel": "Other Financing Cash Flows"
}
}
},
"localname": "OtherFinancingCashFlows",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"lh_OtheracquireesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Other acquirees [Member]",
"label": "Other acquirees [Member]",
"terseLabel": "Other acquirees [Member]"
}
}
},
"localname": "OtheracquireesMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails"
],
"xbrltype": "domainItemType"
},
"lh_OthercountriesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Other countries [Member]",
"label": "Other countries [Member]",
"terseLabel": "Other countries [Member]"
}
}
},
"localname": "OthercountriesMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"lh_OutstandingStockRepurchaseAuthorizationAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "",
"label": "Outstanding Stock Repurchase Authorization [Abstract]",
"terseLabel": "Rollforward of Share Repurchase Program"
}
}
},
"localname": "OutstandingStockRepurchaseAuthorizationAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"lh_PatentsLicensesAndTechnologyMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Patents are the exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law. Licenses are rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory). Technology-based intangible assets are innovations or scientific advances that have not been patented.",
"label": "Patents, Licenses And Technology [Member]",
"terseLabel": "Patents, Licenses And Technology [Member]"
}
}
},
"localname": "PatentsLicensesAndTechnologyMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"lh_PerShareAmountAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "",
"label": "Per Share Amount [Abstract]",
"terseLabel": "Per Share Amount [Abstract]"
}
}
},
"localname": "PerShareAmountAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/EarningsPerShareReconciliationOfBasicEarningsPerShareToDilutedEarningsPerShareDetails"
],
"xbrltype": "stringItemType"
},
"lh_PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit",
"label": "Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit",
"terseLabel": "Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit"
}
}
},
"localname": "PercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "percentItemType"
},
"lh_PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill",
"label": "Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill",
"terseLabel": "Percentage Change in Discount Rate Used to Calculate Fair Value of Goodwill"
}
}
},
"localname": "PercentageChangeinDiscountRateUsedtoCalculateFairValueofGoodwill",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "percentItemType"
},
"lh_PercentageFairValueofGoodwillExceededCarryingValue": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage Fair Value of Goodwill Exceeded Carrying Value",
"label": "Percentage Fair Value of Goodwill Exceeded Carrying Value",
"terseLabel": "Percentage Fair Value of Goodwill Exceeded Carrying Value"
}
}
},
"localname": "PercentageFairValueofGoodwillExceededCarryingValue",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "percentItemType"
},
"lh_PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percent of Fair Value Exceeding Carrying Value Post Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit",
"label": "Percent of Fair Value Exceeding Carrying Value Post Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit",
"terseLabel": "Percent of Fair Value Exceeding Carrying Value Post Percent Change in Discount Rate Used to Calculate Fair Value of Goodwill for Reporting Unit"
}
}
},
"localname": "PercentofFairValueExceedingCarryingValuePostPercentChangeinDiscountRateUsedtoCalculateFairValueofGoodwillforReportingUnit",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "percentItemType"
},
"lh_PercentofRevenueContributed": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percent of Revenue Contributed",
"label": "Percent of Revenue Contributed",
"terseLabel": "Percent of Revenue Contributed"
}
}
},
"localname": "PercentofRevenueContributed",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "percentItemType"
},
"lh_Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percent of remaining performance obligations recognized as revenue in next year",
"label": "Percent of remaining performance obligations recognized as revenue in next year",
"terseLabel": "Percent of remaining performance obligations recognized as revenue in next year"
}
}
},
"localname": "Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "percentItemType"
},
"lh_RecentlyAdoptedAccountingGuidancePolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Recently Adopted Accounting Guidance [Policy Text Block]",
"label": "Recently Adopted Accounting Guidance [Policy Text Block]",
"terseLabel": "Recently Adopted Accounting Guidance [Policy Text Block]"
}
}
},
"localname": "RecentlyAdoptedAccountingGuidancePolicyTextBlock",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationRecentlyAdoptedAccountingStandardsPolicies"
],
"xbrltype": "textBlockItemType"
},
"lh_RestructuringImpairment": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Restructuring Impairment",
"label": "Restructuring Impairment",
"terseLabel": "Asset Impairment Charges"
}
}
},
"localname": "RestructuringImpairment",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_RestructuringReserveSettledWithCashAndOtherAdjustment": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash paid and/or consideration other than cash paid in the period to fully or partially settle a specified, previously accrued type of restructuring cost.",
"label": "Restructuring Reserve Settled With Cash And Other Adjustment",
"negatedLabel": "Cash payments and other adjustments",
"negatedTerseLabel": "Restructuring Reserve Settled With Cash And Other Adjustment"
}
}
},
"localname": "RestructuringReserveSettledWithCashAndOtherAdjustment",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Revolving Credit Facility Accrue Interest Per Annum Base Rate Plus Percentage",
"label": "Revolving Credit Facility Accrue Interest Per Annum Base Rate Plus Percentage",
"terseLabel": "Revolving Credit Facility Accrue Interest Per Annum Base Rate Plus Percentage"
}
}
},
"localname": "RevolvingCreditFacilityAccrueInterestPerAnnumBaseRatePlusPercentage",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "percentItemType"
},
"lh_RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Revolving Credit Facility Accrue Interest per Annum at Libor Plus Margin Percentage",
"label": "Revolving Credit Facility Accrue Interest per Annum at Libor Plus Margin Percentage",
"terseLabel": "Revolving Credit Facility Accrue Interest per Annum at Libor Plus Margin Percentage"
}
}
},
"localname": "RevolvingCreditFacilityAccrueInterestperAnnumatLiborPlusMarginPercentage",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "percentItemType"
},
"lh_RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Revolving Credit Facility Fee Percentage Required to Pay on Outstanding Commitments",
"label": "Revolving Credit Facility Fee Percentage Required to Pay on Outstanding Commitments",
"terseLabel": "Revolving Credit Facility Fee Percentage Required to Pay on Outstanding Commitments"
}
}
},
"localname": "RevolvingCreditFacilityFeePercentageRequiredtoPayonOutstandingCommitments",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "percentItemType"
},
"lh_SalesCommissionAmortizationPeriodMaximum": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Sales Commission Amortization Period Maximum",
"label": "Sales Commission Amortization Period Maximum",
"terseLabel": "Sales Commission Amortization Period Maximum"
}
}
},
"localname": "SalesCommissionAmortizationPeriodMaximum",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "durationItemType"
},
"lh_SalesCommissionAmortizationPeriodMinimum": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Sales Commission Amortization Period Minimum",
"label": "Sales Commission Amortization Period Minimum",
"terseLabel": "Sales Commission Amortization Period Minimum"
}
}
},
"localname": "SalesCommissionAmortizationPeriodMinimum",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "durationItemType"
},
"lh_ScheduleOfOtherIntangibleAssetsByMajorClassAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "",
"label": "Schedule Of Other Intangible Assets By Major Class [Axis]",
"terseLabel": "Schedule Of Other Intangible Assets By Major Class [Axis]"
}
}
},
"localname": "ScheduleOfOtherIntangibleAssetsByMajorClassAxis",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"lh_ScheduleOfOtherIntangibleAssetsByMajorClassDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "",
"label": "Schedule Of Other Intangible Assets By Major Class [Domain]",
"terseLabel": "Schedule Of Other Intangible Assets By Major Class [Domain]"
}
}
},
"localname": "ScheduleOfOtherIntangibleAssetsByMajorClassDomain",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"lh_ScheduleofBusinessAcquisitionsbyAcquisitionAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of Business Acquisitions, by Acquisition [Abstract]",
"label": "Schedule of Business Acquisitions, by Acquisition [Abstract]"
}
}
},
"localname": "ScheduleofBusinessAcquisitionsbyAcquisitionAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"xbrltype": "stringItemType"
},
"lh_SegmentReconciliationofOperatingIncometoConsolidatedAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Segment Reconciliation of Operating Income to Consolidated [Abstract]",
"label": "Segment Reconciliation of Operating Income to Consolidated [Abstract]"
}
}
},
"localname": "SegmentReconciliationofOperatingIncometoConsolidatedAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"xbrltype": "stringItemType"
},
"lh_SeniorLongTermNotesDue2020Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A senior note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.",
"label": "Senior Long Term Notes Due2020 Member",
"terseLabel": "Senior Long Term Notes Due2020 Member"
}
}
},
"localname": "SeniorLongTermNotesDue2020Member",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "domainItemType"
},
"lh_SeniorNotesBecameDueDuringQuarter": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Senior Notes Became Due During Quarter",
"label": "Senior Notes Became Due During Quarter",
"terseLabel": "Senior Notes Became Due During Quarter"
}
}
},
"localname": "SeniorNotesBecameDueDuringQuarter",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_SeniorNotesDue2020Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A senior note is a bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors.",
"label": "Senior notes due 2020 [Member]",
"terseLabel": "Senior notes due 2020 [Member]"
}
}
},
"localname": "SeniorNotesDue2020Member",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "domainItemType"
},
"lh_SeniorNotesDue2022Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Senior notes due 2022 [Member]",
"label": "Senior notes due 2022 [Member]",
"terseLabel": "Senior notes due 2022 [Member]"
}
}
},
"localname": "SeniorNotesDue2022Member",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "domainItemType"
},
"lh_SeniorNotesFairValue": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Estimated fair value of the debt instrument (senior notes) at the balance-sheet date",
"label": "Senior Notes Fair Value",
"terseLabel": "Fair market value of senior notes"
}
}
},
"localname": "SeniorNotesFairValue",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_Seniornotesdue2023Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Senior notes due 2023 [Member]",
"label": "Senior notes due 2023 [Member]",
"terseLabel": "Senior notes due 2023 [Member]"
}
}
},
"localname": "Seniornotesdue2023Member",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "domainItemType"
},
"lh_Seniornotesdue2024MemberMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Senior notes due 2024 [Member]",
"label": "Senior notes due 2024 [Member] [Member]",
"terseLabel": "Senior notes due 2024 [Member] [Member]"
}
}
},
"localname": "Seniornotesdue2024MemberMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "domainItemType"
},
"lh_Seniornotesdue2025MemberMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Senior notes due 2025 [Member] [Member]",
"label": "Senior notes due 2025 [Member] [Member]",
"terseLabel": "Senior notes due 2025 [Member] [Member]"
}
}
},
"localname": "Seniornotesdue2025MemberMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "domainItemType"
},
"lh_Seniornotesdue2027Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Senior notes due 2027 [Member]",
"label": "Senior notes due 2027 [Member]",
"terseLabel": "Senior notes due 2027 [Member]"
}
}
},
"localname": "Seniornotesdue2027Member",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "domainItemType"
},
"lh_Seniornotesdue2045Member": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Senior notes due 2045 [Member]",
"label": "Senior notes due 2045 [Member]",
"terseLabel": "Senior notes due 2045 [Member]"
}
}
},
"localname": "Seniornotesdue2045Member",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"lh_SharesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "",
"label": "Shares [Abstract]",
"terseLabel": "Shares [Abstract]"
}
}
},
"localname": "SharesAbstract",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/EarningsPerShareReconciliationOfBasicEarningsPerShareToDilutedEarningsPerShareDetails"
],
"xbrltype": "stringItemType"
},
"lh_Shorttermdebtissuancecosts": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Short term debt issuance costs",
"label": "Short term debt issuance costs",
"terseLabel": "Short term debt issuance costs"
}
}
},
"localname": "Shorttermdebtissuancecosts",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Term Loan Accrue Interest Per Annum Base Rate Plus Percentage",
"label": "Term Loan Accrue Interest Per Annum Base Rate Plus Percentage",
"terseLabel": "Term Loan Accrue Interest Per Annum Base Rate Plus Percentage"
}
}
},
"localname": "TermLoanAccrueInterestPerAnnumBaseRatePlusPercentage",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "percentItemType"
},
"lh_TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Term Loan Accrue Interest per Annum at Libor Plus Margin Percentage",
"label": "Term Loan Accrue Interest per Annum at Libor Plus Margin Percentage",
"terseLabel": "Term Loan Accrue Interest per Annum at Libor Plus Margin Percentage"
}
}
},
"localname": "TermLoanAccrueInterestperAnnumatLiborPlusMarginPercentage",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "percentItemType"
},
"lh_TermLoanandRevolvingCreditFacilityMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Term Loan and Revolving Credit Facility [Member]",
"label": "Term Loan and Revolving Credit Facility [Member]",
"terseLabel": "Term Loan and Revolving Credit Facility [Member]"
}
}
},
"localname": "TermLoanandRevolvingCreditFacilityMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "domainItemType"
},
"lh_ThirdpartyMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Third party [Member]",
"label": "Third party [Member]",
"terseLabel": "Third party [Member]"
}
}
},
"localname": "ThirdpartyMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"lh_Totalacquisitionconsiderationcashstocknotesetc.": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Total acquisition consideration (cash, stock, notes, etc.)",
"label": "Total acquisition consideration (cash, stock, notes, etc.)",
"terseLabel": "Total acquisition consideration (cash, stock, notes, etc.)"
}
}
},
"localname": "Totalacquisitionconsiderationcashstocknotesetc.",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_UnbilledContractsReceivableMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Unbilled Contracts Receivable [Member]",
"label": "Unbilled Contracts Receivable [Member]",
"terseLabel": "Unbilled Contracts Receivable [Member]"
}
}
},
"localname": "UnbilledContractsReceivableMember",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "domainItemType"
},
"lh_UnbilledServicesAllowanceforCreditLoss": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Unbilled Services, Allowance for Credit Loss",
"label": "Unbilled Services, Allowance for Credit Loss",
"terseLabel": "Unbilled Services, Allowance for Credit Loss"
}
}
},
"localname": "UnbilledServicesAllowanceforCreditLoss",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_UnbilledServicesCreditLossExpenseReversal": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Unbilled Services, Credit Loss Expense (Reversal)",
"label": "Unbilled Services, Credit Loss Expense (Reversal)",
"terseLabel": "Unbilled Services, Credit Loss Expense (Reversal)"
}
}
},
"localname": "UnbilledServicesCreditLossExpenseReversal",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_Unusedfacilityrestructuringreserves": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Unused facility restructuring reserves",
"label": "Unused facility restructuring reserves",
"negatedTerseLabel": "Unused facility restructuring reserves",
"terseLabel": "Unused facility restructuring reserves"
}
}
},
"localname": "Unusedfacilityrestructuringreserves",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit",
"label": "Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit",
"terseLabel": "Value of Goodwill Impairment Following a Percentage Change in the Discount Rate Used to Calculate Goodwill for Reporting Unit"
}
}
},
"localname": "ValueofGoodwillImpairmentFollowingaPercentageChangeintheDiscountRateUsedtoCalculateGoodwillforReportingUnit",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value",
"label": "Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value",
"terseLabel": "Value of Reporting Units Goodwill Fair Value Exceeds Carrying Value"
}
}
},
"localname": "ValueofReportingUnitsGoodwillFairValueExceedsCarryingValue",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_ValueofReportingUnitsGoodwillFollowingImpairment": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Value of Reporting Unit's Goodwill Following Impairment",
"label": "Value of Reporting Unit's Goodwill Following Impairment",
"terseLabel": "Value of Reporting Unit's Goodwill Following Impairment"
}
}
},
"localname": "ValueofReportingUnitsGoodwillFollowingImpairment",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "monetaryItemType"
},
"lh_ZeroCouponConvertibleSubordinatedNotesLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Zero Coupon Convertible Subordinated Notes [Line Items]",
"label": "Zero Coupon Convertible Subordinated Notes [Line Items]",
"terseLabel": "Zero Coupon Convertible Subordinated Notes [Line Items]"
}
}
},
"localname": "ZeroCouponConvertibleSubordinatedNotesLineItems",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtConvertibleSubordinatedNotesDetails"
],
"xbrltype": "stringItemType"
},
"lh_ZeroCouponConvertibleSubordinatedNotesTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Zero Coupon Convertible Subordinated Notes [Table]",
"label": "Zero Coupon Convertible Subordinated Notes [Table]",
"terseLabel": "Zero Coupon Convertible Subordinated Notes [Table]"
}
}
},
"localname": "ZeroCouponConvertibleSubordinatedNotesTable",
"nsuri": "http://www.labcorp.com/20200331",
"presentation": [
"http://www.labcorp.com/role/DebtConvertibleSubordinatedNotesDetails"
],
"xbrltype": "stringItemType"
},
"srt_ConsolidationItemsAxis": {
"auth_ref": [
"r145",
"r156"
],
"lang": {
"en-US": {
"role": {
"label": "Consolidation Items [Axis]",
"terseLabel": "Consolidation Items [Axis]"
}
}
},
"localname": "ConsolidationItemsAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables"
],
"xbrltype": "stringItemType"
},
"srt_ConsolidationItemsDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Consolidation Items [Domain]",
"terseLabel": "Consolidation Items [Domain]"
}
}
},
"localname": "ConsolidationItemsDomain",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables"
],
"xbrltype": "domainItemType"
},
"srt_EquityMethodInvesteeNameDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Investment, Name [Domain]",
"terseLabel": "Investment, Name [Domain]"
}
}
},
"localname": "EquityMethodInvesteeNameDomain",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails"
],
"xbrltype": "domainItemType"
},
"srt_EuropeMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Europe [Member]",
"terseLabel": "Europe [Member]"
}
}
},
"localname": "EuropeMember",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"srt_MajorCustomersAxis": {
"auth_ref": [
"r160",
"r261",
"r265",
"r418"
],
"lang": {
"en-US": {
"role": {
"label": "Customer [Axis]",
"terseLabel": "Customer [Axis]"
}
}
},
"localname": "MajorCustomersAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "stringItemType"
},
"srt_MaximumMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Maximum [Member]",
"terseLabel": "Maximum [Member]"
}
}
},
"localname": "MaximumMember",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/LeasesDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "domainItemType"
},
"srt_MinimumMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Minimum [Member]",
"terseLabel": "Minimum [Member]"
}
}
},
"localname": "MinimumMember",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/LeasesDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "domainItemType"
},
"srt_NameOfMajorCustomerDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Customer [Domain]",
"terseLabel": "Customer [Domain]"
}
}
},
"localname": "NameOfMajorCustomerDomain",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "domainItemType"
},
"srt_ProductOrServiceAxis": {
"auth_ref": [
"r158",
"r261",
"r263",
"r415",
"r416"
],
"lang": {
"en-US": {
"role": {
"label": "Product and Service [Axis]",
"terseLabel": "Product and Service [Axis]"
}
}
},
"localname": "ProductOrServiceAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "stringItemType"
},
"srt_ProductsAndServicesDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Product and Service [Domain]",
"terseLabel": "Product and Service [Domain]"
}
}
},
"localname": "ProductsAndServicesDomain",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "domainItemType"
},
"srt_RangeAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statistical Measurement [Axis]",
"terseLabel": "Statistical Measurement [Axis]"
}
}
},
"localname": "RangeAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"http://www.labcorp.com/role/LeasesDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "stringItemType"
},
"srt_RangeMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statistical Measurement [Domain]",
"terseLabel": "Statistical Measurement [Domain]"
}
}
},
"localname": "RangeMember",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"http://www.labcorp.com/role/LeasesDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "domainItemType"
},
"srt_RestatementAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Restatement [Axis]",
"terseLabel": "Restatement [Axis]"
}
}
},
"localname": "RestatementAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals"
],
"xbrltype": "stringItemType"
},
"srt_RestatementDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Restatement [Domain]",
"terseLabel": "Restatement [Domain]"
}
}
},
"localname": "RestatementDomain",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals"
],
"xbrltype": "domainItemType"
},
"srt_ScenarioUnspecifiedDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Scenario [Domain]",
"terseLabel": "Scenario [Domain]"
}
}
},
"localname": "ScenarioUnspecifiedDomain",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
"auth_ref": [
"r170"
],
"lang": {
"en-US": {
"role": {
"label": "Investment, Name [Axis]",
"terseLabel": "Investment, Name [Axis]"
}
}
},
"localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails"
],
"xbrltype": "stringItemType"
},
"srt_SegmentGeographicalDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Geographical [Domain]",
"terseLabel": "Geographical [Domain]"
}
}
},
"localname": "SegmentGeographicalDomain",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"srt_StatementGeographicalAxis": {
"auth_ref": [
"r159",
"r261",
"r264",
"r417",
"r419",
"r420"
],
"lang": {
"en-US": {
"role": {
"label": "Geographical [Axis]",
"terseLabel": "Geographical [Axis]"
}
}
},
"localname": "StatementGeographicalAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "stringItemType"
},
"srt_StatementScenarioAxis": {
"auth_ref": [
"r230",
"r388"
],
"lang": {
"en-US": {
"role": {
"label": "Scenario [Axis]",
"terseLabel": "Scenario [Axis]",
"verboseLabel": "Statement, Scenario [Axis]"
}
}
},
"localname": "StatementScenarioAxis",
"nsuri": "http://fasb.org/srt/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AccountingGuidanceMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Previous accounting guidance and the new accounting guidance.",
"label": "Accounting Guidance [Domain]",
"terseLabel": "Accounting Guidance [Domain]"
}
}
},
"localname": "AccountingGuidanceMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_AccountingPoliciesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Accounting Policies [Abstract]"
}
}
},
"localname": "AccountingPoliciesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_AccountsNotesAndLoansReceivableLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
"terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
}
}
},
"localname": "AccountsNotesAndLoansReceivableLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AccountsPayableCurrent": {
"auth_ref": [
"r43"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Accounts Payable, Current",
"terseLabel": "Accounts Payable, Current"
}
}
},
"localname": "AccountsPayableCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccountsPayableMember": {
"auth_ref": [
"r22"
],
"lang": {
"en-US": {
"role": {
"documentation": "Obligations incurred and payable to vendors for goods and services received.",
"label": "Accounts Payable [Member]",
"terseLabel": "Accounts Payable [Member]"
}
}
},
"localname": "AccountsPayableMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_AccountsReceivableMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
"label": "Accounts Receivable [Member]",
"terseLabel": "Accounts Receivable [Member]"
}
}
},
"localname": "AccountsReceivableMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_AccountsReceivableNetCurrent": {
"auth_ref": [
"r16",
"r32",
"r162",
"r163",
"r262"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
"label": "Accounts Receivable, after Allowance for Credit Loss, Current",
"terseLabel": "Accounts Receivable, after Allowance for Credit Loss, Current"
}
}
},
"localname": "AccountsReceivableNetCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccruedLiabilitiesCurrent": {
"auth_ref": [
"r48"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Accrued Liabilities, Current",
"terseLabel": "Accrued Liabilities, Current"
}
}
},
"localname": "AccruedLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccruedLiabilitiesMember": {
"auth_ref": [
"r48"
],
"lang": {
"en-US": {
"role": {
"documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
"label": "Accrued Liabilities [Member]",
"terseLabel": "Accrued Liabilities [Member]"
}
}
},
"localname": "AccruedLiabilitiesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_AccruedSalesCommissionCurrentAndNoncurrent": {
"auth_ref": [
"r26",
"r28",
"r397",
"r407"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions.",
"label": "Accrued Sales Commission",
"terseLabel": "Accrued Sales Commission"
}
}
},
"localname": "AccruedSalesCommissionCurrentAndNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
"auth_ref": [
"r64",
"r69"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
"label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
"periodEndLabel": "Net Benefit Plan Adjustments, Ending balance",
"periodStartLabel": "Net Benefit Plan Adjustments, Beginning balance"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
"auth_ref": [
"r62",
"r66",
"r68",
"r69",
"r372",
"r376",
"r379"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
"label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
"periodEndLabel": "Foreign Currency Translation Adjustments, Ending balance",
"periodStartLabel": "Foreign Currency Translation Adjustments, Beginning balance"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
"terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquity",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
"auth_ref": [
"r66",
"r68",
"r69"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
"label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
"periodEndLabel": "Accumulated Other Comprehensive Earnings, Ending balance",
"periodStartLabel": "Accumulated Other Comprehensive Earnings, Beginning balance",
"terseLabel": "Total liabilities and shareholders' equity"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
"label": "Accumulated Other Comprehensive Income (Loss) [Table]",
"terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeLossTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquity",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
"auth_ref": [
"r65",
"r69",
"r70",
"r334"
],
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
"label": "AOCI Attributable to Parent [Member]",
"terseLabel": "Accumulated Other Comprehensive Income [Member]"
}
}
},
"localname": "AccumulatedOtherComprehensiveIncomeMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
"auth_ref": [
"r197"
],
"lang": {
"en-US": {
"role": {
"documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
"label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
"terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life"
}
}
},
"localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_AdditionalPaidInCapitalCommonStock": {
"auth_ref": [
"r33"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
"label": "Additional Paid in Capital, Common Stock",
"terseLabel": "Additional paid-in capital"
}
}
},
"localname": "AdditionalPaidInCapitalCommonStock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdditionalPaidInCapitalMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
"label": "Additional Paid-in Capital [Member]",
"terseLabel": "Additional Paid-in Capital [Member]"
}
}
},
"localname": "AdditionalPaidInCapitalMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
"auth_ref": [
"r296",
"r297",
"r298",
"r299"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
"label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
"terseLabel": "Stock compensation"
}
}
},
"localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
"terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:"
}
}
},
"localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
"auth_ref": [
"r164",
"r175"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of allowance for credit loss on financing receivable.",
"label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]",
"terseLabel": "Financing Receivable, Allowance for Credit Loss [Table Text Block]"
}
}
},
"localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_AllowanceForDoubtfulAccountsReceivable": {
"auth_ref": [
"r165",
"r171",
"r172",
"r174"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of allowance for credit loss on accounts receivable.",
"label": "Accounts Receivable, Allowance for Credit Loss",
"terseLabel": "Accounts Receivable, Allowance for Credit Loss"
}
}
},
"localname": "AllowanceForDoubtfulAccountsReceivable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AmortizationOfDeferredSalesCommissions": {
"auth_ref": [
"r87",
"r104"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
"label": "Amortization of Deferred Sales Commissions",
"terseLabel": "Amortization of Deferred Sales Commissions"
}
}
},
"localname": "AmortizationOfDeferredSalesCommissions",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AmortizationOfIntangibleAssets": {
"auth_ref": [
"r104",
"r194",
"r202"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
"label": "Amortization of Intangible Assets",
"terseLabel": "Amortization of intangibles and other assets",
"verboseLabel": "Amortization of intangible assets"
}
}
},
"localname": "AmortizationOfIntangibleAssets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AmountOfDeferredCostsRelatedToLongTermContracts": {
"auth_ref": [
"r39"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of deferred costs for long-term contracts and programs. Includes, but is not limited to, initial tooling costs and deferred production costs.",
"label": "Amount of Deferred Costs Related to Long-term Contracts",
"terseLabel": "Amount of Deferred Costs Related to Long-term Contracts"
}
}
},
"localname": "AmountOfDeferredCostsRelatedToLongTermContracts",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
"auth_ref": [
"r130"
],
"lang": {
"en-US": {
"role": {
"documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
"label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
"terseLabel": "Stock options (in shares)"
}
}
},
"localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/EarningsPerSharePotentialCommonSharesNotIncludedInComputationOfDilutedEarningsPerShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_AssetImpairmentCharges": {
"auth_ref": [
"r104",
"r208"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
},
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
"label": "Asset Impairment Charges",
"terseLabel": "Asset Impairment Charges"
}
}
},
"localname": "AssetImpairmentCharges",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_Assets": {
"auth_ref": [
"r150",
"r395",
"r406"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets",
"terseLabel": "Assets",
"totalLabel": "Total assets"
}
}
},
"localname": "Assets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Assets [Abstract]",
"terseLabel": "ASSETS"
}
}
},
"localname": "AssetsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsCurrent": {
"auth_ref": [
"r18",
"r20",
"r61"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets, Current",
"terseLabel": "Assets, Current",
"totalLabel": "Total current assets"
}
}
},
"localname": "AssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Assets, Current [Abstract]",
"terseLabel": "Current assets:",
"verboseLabel": "Current Assets:"
}
}
},
"localname": "AssetsCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets [Member]",
"terseLabel": "Assets [Member]"
}
}
},
"localname": "AssetsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_BalanceSheetLocationAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by location on balance sheet (statement of financial position).",
"label": "Balance Sheet Location [Axis]",
"terseLabel": "Balance Sheet Location [Axis]"
}
}
},
"localname": "BalanceSheetLocationAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_BalanceSheetLocationDomain": {
"auth_ref": [
"r346",
"r349"
],
"lang": {
"en-US": {
"role": {
"documentation": "Location in the balance sheet (statement of financial position).",
"label": "Balance Sheet Location [Domain]",
"terseLabel": "Balance Sheet Location [Domain]"
}
}
},
"localname": "BalanceSheetLocationDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_BusinessAcquisitionAcquireeDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
"label": "Business Acquisition, Acquiree [Domain]",
"terseLabel": "Business Acquisition, Acquiree [Domain]"
}
}
},
"localname": "BusinessAcquisitionAcquireeDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables"
],
"xbrltype": "domainItemType"
},
"us-gaap_BusinessAcquisitionAxis": {
"auth_ref": [
"r318",
"r319"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by business combination or series of individually immaterial business combinations.",
"label": "Business Acquisition [Axis]",
"terseLabel": "Business Acquisition [Axis]"
}
}
},
"localname": "BusinessAcquisitionAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessAcquisitionLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Business Acquisition [Line Items]",
"terseLabel": "Business Acquisition [Line Items]"
}
}
},
"localname": "BusinessAcquisitionLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
"auth_ref": [
"r315",
"r316"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
"label": "Business Acquisition, Pro Forma Information [Table Text Block]",
"terseLabel": "Business Acquisition, Pro Forma Information [Table Text Block]"
}
}
},
"localname": "BusinessAcquisitionProFormaInformationTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
"auth_ref": [
"r315",
"r316"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
"label": "Business Acquisition, Pro Forma Net Income (Loss)",
"terseLabel": "Business Acquisition, Pro Forma Net Income (Loss)"
}
}
},
"localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessAcquisitionsProFormaRevenue": {
"auth_ref": [
"r315",
"r316"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
"label": "Business Acquisition, Pro Forma Revenue",
"terseLabel": "Business Acquisition, Pro Forma Revenue"
}
}
},
"localname": "BusinessAcquisitionsProFormaRevenue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
"auth_ref": [
"r103",
"r327"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
"label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
"terseLabel": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability"
}
}
},
"localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationDisclosureTextBlock": {
"auth_ref": [
"r328"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
"label": "Business Combination Disclosure [Text Block]",
"terseLabel": "Business Combination Disclosure [Text Block]"
}
}
},
"localname": "BusinessCombinationDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitions"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
"auth_ref": [
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of assets acquired at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
"negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
"auth_ref": [
"r321"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of lease obligation assumed in business combination.",
"label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation",
"negatedTerseLabel": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
"auth_ref": [
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
"negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
"auth_ref": [
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
"negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
"auth_ref": [
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
"terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
"auth_ref": [
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
"negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
"auth_ref": [
"r321"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
"negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
"auth_ref": [
"r321"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
"terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
"auth_ref": [
"r321"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
"negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
"auth_ref": [
"r301",
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
"label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
"negatedTerseLabel": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
"auth_ref": [
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
"terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
"auth_ref": [
"r320",
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
"terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
"auth_ref": [
"r320",
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of inventory recognized as of the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
"terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
"auth_ref": [
"r321"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities assumed at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
"negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
"auth_ref": [
"r320",
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
"terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": {
"auth_ref": [
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets",
"terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": {
"auth_ref": [
"r321"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities",
"negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
"auth_ref": [
"r320",
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
"label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
"terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
"auth_ref": [
"r321"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
"label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
"negatedTerseLabel": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
"terseLabel": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net"
}
}
},
"localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_BusinessCombinationsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Business Combinations [Abstract]"
}
}
},
"localname": "BusinessCombinationsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_BusinessExitCosts1": {
"auth_ref": [
"r104",
"r215",
"r220",
"r225"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
"label": "Business Exit Costs",
"terseLabel": "Restructuring charges related to contractual obligations associated with leased facilities and other facility related costs"
}
}
},
"localname": "BusinessExitCosts1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
"auth_ref": [
"r108",
"r109",
"r110"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
"label": "Capital Expenditures Incurred but Not yet Paid",
"negatedTerseLabel": "Capital Expenditures Incurred but Not yet Paid"
}
}
},
"localname": "CapitalExpendituresIncurredButNotYetPaid",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalizedContractCostAmortization": {
"auth_ref": [
"r181"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
"label": "Capitalized Contract Cost, Amortization",
"terseLabel": "Capitalized Contract Cost, Amortization"
}
}
},
"localname": "CapitalizedContractCostAmortization",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalizedContractCostAmortizationPeriod": {
"auth_ref": [
"r179"
],
"lang": {
"en-US": {
"role": {
"documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
"label": "Capitalized Contract Cost, Amortization Period",
"terseLabel": "Capitalized Contract Cost, Amortization Period"
}
}
},
"localname": "CapitalizedContractCostAmortizationPeriod",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "durationItemType"
},
"us-gaap_CapitalizedContractCostNet": {
"auth_ref": [
"r180"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
"label": "Capitalized Contract Cost, Net",
"terseLabel": "Capitalized Contract Cost, Net"
}
}
},
"localname": "CapitalizedContractCostNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CapitalizedContractCostTableTextBlock": {
"auth_ref": [
"r182"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of cost capitalized in obtaining or fulfilling contract with customer.",
"label": "Capitalized Contract Cost [Table Text Block]",
"terseLabel": "Capitalized Contract Cost [Table Text Block]"
}
}
},
"localname": "CapitalizedContractCostTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CashAndCashEquivalentsAtCarryingValue": {
"auth_ref": [
"r14",
"r40",
"r106"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
"label": "Cash and Cash Equivalents, at Carrying Value",
"negatedTerseLabel": "Cash and cash equivalents",
"periodEndLabel": "Cash and cash equivalents at end of period",
"periodStartLabel": "Cash and cash equivalents at beginning of period",
"terseLabel": "Cash and cash equivalents"
}
}
},
"localname": "CashAndCashEquivalentsAtCarryingValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashAndCashEquivalentsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash and Cash Equivalents [Member]",
"terseLabel": "Cash and Cash Equivalents [Member]"
}
}
},
"localname": "CashAndCashEquivalentsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
"auth_ref": [
"r101",
"r375"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
"totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
"terseLabel": "Disclosure of non-cash financing and investing activities:"
}
}
},
"localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
"auth_ref": [
"r111"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
"label": "Cash Flow, Supplemental Disclosures [Text Block]",
"terseLabel": "Supplemental Cash Flow Information"
}
}
},
"localname": "CashFlowSupplementalDisclosuresTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/LeasesTables",
"http://www.labcorp.com/role/SupplementalCashFlowInformation",
"http://www.labcorp.com/role/SupplementalCashFlowInformationTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CashSurrenderValueFairValueDisclosure": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
"label": "Cash Surrender Value, Fair Value Disclosure",
"terseLabel": "Cash Surrender Value, Fair Value Disclosure"
}
}
},
"localname": "CashSurrenderValueFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
"auth_ref": [
"r360"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.",
"label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
"terseLabel": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge"
}
}
},
"localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ClassOfStockDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
"label": "Class of Stock [Domain]",
"terseLabel": "Class of Stock [Domain]"
}
}
},
"localname": "ClassOfStockDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ClassOfStockLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Class of Stock [Line Items]",
"terseLabel": "Class of Stock [Line Items]"
}
}
},
"localname": "ClassOfStockLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Commitments and Contingencies Disclosure [Abstract]"
}
}
},
"localname": "CommitmentsAndContingenciesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
"auth_ref": [
"r228",
"r236"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for commitments and contingencies.",
"label": "Commitments and Contingencies Disclosure [Text Block]",
"terseLabel": "Commitments and Contingencies"
}
}
},
"localname": "CommitmentsAndContingenciesDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CommitmentsAndContingencies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CommonStockMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Stock that is subordinate to all other stock of the issuer.",
"label": "Common Stock [Member]",
"terseLabel": "Common Stock [Member]"
}
}
},
"localname": "CommonStockMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommonStockParOrStatedValuePerShare": {
"auth_ref": [
"r31"
],
"lang": {
"en-US": {
"role": {
"documentation": "Face amount or stated value per share of common stock.",
"label": "Common Stock, Par or Stated Value Per Share",
"terseLabel": "Common Stock, Par or Stated Value Per Share"
}
}
},
"localname": "CommonStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_CommonStockSharesAuthorized": {
"auth_ref": [
"r31"
],
"lang": {
"en-US": {
"role": {
"documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
"label": "Common Stock, Shares Authorized",
"terseLabel": "Common Stock, Shares Authorized"
}
}
},
"localname": "CommonStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesIssued": {
"auth_ref": [
"r31"
],
"lang": {
"en-US": {
"role": {
"documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
"label": "Common Stock, Shares, Issued",
"periodEndLabel": "Common shares issued, ending balance (in shares)",
"periodStartLabel": "Common shares issued, beginning balance (in shares)",
"terseLabel": "Common Stock, Shares, Issued"
}
}
},
"localname": "CommonStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesOutstanding": {
"auth_ref": [
"r31",
"r245"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
"label": "Common Stock, Shares, Outstanding",
"periodEndLabel": "Common shares outstanding, ending balance (in shares)",
"periodStartLabel": "Common shares outstanding, beginning balance (in shares)",
"terseLabel": "Common stock, shares outstanding (in shares)"
}
}
},
"localname": "CommonStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockValue": {
"auth_ref": [
"r31"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Common Stock, Value, Issued",
"terseLabel": "Retained earnings"
}
}
},
"localname": "CommonStockValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CompensationAndRetirementDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Retirement Benefits [Abstract]"
}
}
},
"localname": "CompensationAndRetirementDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_ComprehensiveIncomeNetOfTax": {
"auth_ref": [
"r73",
"r75",
"r76"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
"label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
"totalLabel": "Comprehensive earnings attributable to Laboratory Corporation of America Holdings"
}
}
},
"localname": "ComprehensiveIncomeNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]"
}
}
},
"localname": "ComprehensiveIncomeNetOfTaxAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
"auth_ref": [
"r73",
"r75",
"r330",
"r337"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
"label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
"totalLabel": "Comprehensive earnings"
}
}
},
"localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure": {
"auth_ref": [
"r363"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of contingent consideration in a business combination that is classified in shareholders' equity.",
"label": "Contingent Consideration Classified as Equity, Fair Value Disclosure",
"terseLabel": "Contingent Consideration Classified as Equity, Fair Value Disclosure"
}
}
},
"localname": "ContingentConsiderationClassifiedAsEquityFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
"auth_ref": [
"r258"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of contract balances and changes in contract balances.",
"label": "Contract with Customer, Asset and Liability [Table Text Block]",
"terseLabel": "Contract with Customer, Asset and Liability [Table Text Block]"
}
}
},
"localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ContractWithCustomerAssetGross": {
"auth_ref": [
"r255",
"r257",
"r262"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
"label": "Contract with Customer, Asset, before Allowance for Credit Loss",
"terseLabel": "Contract with Customer, Asset, before Allowance for Credit Loss"
}
}
},
"localname": "ContractWithCustomerAssetGross",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ContractWithCustomerBasisOfPricingAxis": {
"auth_ref": [
"r266"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by basis of pricing for contract representing right to consideration in exchange for good or service transferred to customer.",
"label": "Contract with Customer, Basis of Pricing [Axis]",
"terseLabel": "Contract with Customer, Basis of Pricing [Axis]"
}
}
},
"localname": "ContractWithCustomerBasisOfPricingAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ContractWithCustomerBasisOfPricingDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Basis of pricing for contract with customer. Includes, but is not limited to, fixed-price and time-and-materials contracts.",
"label": "Contract with Customer, Basis of Pricing [Domain]",
"terseLabel": "Contract with Customer, Basis of Pricing [Domain]"
}
}
},
"localname": "ContractWithCustomerBasisOfPricingDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ContractWithCustomerDurationAxis": {
"auth_ref": [
"r267"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
"label": "Contract with Customer, Duration [Axis]",
"terseLabel": "Contract with Customer, Duration [Axis]"
}
}
},
"localname": "ContractWithCustomerDurationAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ContractWithCustomerDurationDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
"label": "Contract with Customer, Duration [Domain]",
"terseLabel": "Contract with Customer, Duration [Domain]"
}
}
},
"localname": "ContractWithCustomerDurationDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ContractWithCustomerLiability": {
"auth_ref": [
"r255",
"r256",
"r262"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
"label": "Contract with Customer, Liability",
"terseLabel": "Contract with Customer, Liability"
}
}
},
"localname": "ContractWithCustomerLiability",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
"auth_ref": [
"r259"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.",
"label": "Contract with Customer, Performance Obligation Satisfied in Previous Period",
"terseLabel": "Contract with Customer, Performance Obligation Satisfied in Previous Period"
}
}
},
"localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ContractWithCustomerSalesChannelAxis": {
"auth_ref": [
"r269"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by sales channel for delivery of good or service in contract with customer.",
"label": "Contract with Customer, Sales Channel [Axis]",
"terseLabel": "Contract with Customer, Sales Channel [Axis]"
}
}
},
"localname": "ContractWithCustomerSalesChannelAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_ContractWithCustomerSalesChannelDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
"label": "Contract with Customer, Sales Channel [Domain]",
"terseLabel": "Contract with Customer, Sales Channel [Domain]"
}
}
},
"localname": "ContractWithCustomerSalesChannelDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"us-gaap_CorporateMember": {
"auth_ref": [
"r142"
],
"lang": {
"en-US": {
"role": {
"documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
"label": "Corporate Segment [Member]",
"terseLabel": "Corporate Segment [Member]"
}
}
},
"localname": "CorporateMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CostOfRevenue": {
"auth_ref": [
"r86"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_GrossProfit",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
"label": "Cost of Revenue",
"terseLabel": "Cost of Revenue"
}
}
},
"localname": "CostOfRevenue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CreditFacilityAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
"label": "Credit Facility [Axis]",
"terseLabel": "Credit Facility [Axis]"
}
}
},
"localname": "CreditFacilityAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CreditFacilityDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
"label": "Credit Facility [Domain]",
"terseLabel": "Credit Facility [Domain]"
}
}
},
"localname": "CreditFacilityDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CurrencySwapMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
"label": "Currency Swap [Member]",
"terseLabel": "Currency Swap [Member]"
}
}
},
"localname": "CurrencySwapMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_CustomerRelationshipsMember": {
"auth_ref": [
"r324"
],
"lang": {
"en-US": {
"role": {
"documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
"label": "Customer Relationships [Member]",
"terseLabel": "Customer Relationships [Member]"
}
}
},
"localname": "CustomerRelationshipsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtConversionLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Debt Conversion [Line Items]",
"terseLabel": "Debt Conversion [Line Items]"
}
}
},
"localname": "DebtConversionLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtConversionTable": {
"auth_ref": [
"r108",
"r110"
],
"lang": {
"en-US": {
"role": {
"documentation": "A table that contains information on an original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
"label": "Debt Conversion [Table]",
"terseLabel": "Debt Conversion [Table]"
}
}
},
"localname": "DebtConversionTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtCurrent": {
"auth_ref": [
"r46"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
"label": "Debt, Current",
"terseLabel": "Debt, Current",
"verboseLabel": "Total short-term borrowings and current portion of long-term debt"
}
}
},
"localname": "DebtCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DebtDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Debt Disclosure [Abstract]"
}
}
},
"localname": "DebtDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_DebtDisclosureTextBlock": {
"auth_ref": [
"r241"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
"label": "Debt Disclosure [Text Block]",
"terseLabel": "Debt"
}
}
},
"localname": "DebtDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/Debt"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_DebtInstrumentAxis": {
"auth_ref": [
"r25",
"r26",
"r27",
"r396",
"r398",
"r405"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
"label": "Debt Instrument [Axis]",
"terseLabel": "Debt Instrument [Axis]"
}
}
},
"localname": "DebtInstrumentAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
"label": "Debt Instrument, Basis Spread on Variable Rate",
"terseLabel": "Debt Instrument, Basis Spread on Variable Rate"
}
}
},
"localname": "DebtInstrumentBasisSpreadOnVariableRate1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
"auth_ref": [
"r50",
"r240",
"r382"
],
"lang": {
"en-US": {
"role": {
"documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
"label": "Debt Instrument, Interest Rate, Effective Percentage",
"netLabel": "Debt Instrument, Interest Rate, Effective Percentage",
"terseLabel": "Debt Instrument, Interest Rate, Effective Percentage",
"verboseLabel": "Debt Instrument, Interest Rate, Effective Percentage"
}
}
},
"localname": "DebtInstrumentInterestRateEffectivePercentage",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_DebtInstrumentInterestRateStatedPercentage": {
"auth_ref": [
"r50"
],
"lang": {
"en-US": {
"role": {
"documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
"label": "Debt Instrument, Interest Rate, Stated Percentage",
"terseLabel": "Debt Instrument, Interest Rate, Stated Percentage",
"verboseLabel": "Stated interest rate percentage"
}
}
},
"localname": "DebtInstrumentInterestRateStatedPercentage",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_DebtInstrumentLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Debt Instrument [Line Items]",
"terseLabel": "Debt Instrument [Line Items]"
}
}
},
"localname": "DebtInstrumentLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DebtInstrumentNameDomain": {
"auth_ref": [
"r51"
],
"lang": {
"en-US": {
"role": {
"documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
"label": "Debt Instrument, Name [Domain]",
"terseLabel": "Debt Instrument, Name [Domain]"
}
}
},
"localname": "DebtInstrumentNameDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DebtInstrumentTable": {
"auth_ref": [
"r51",
"r114",
"r246",
"r249",
"r250",
"r251",
"r381",
"r382",
"r384",
"r404"
],
"lang": {
"en-US": {
"role": {
"documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
"label": "Schedule of Long-term Debt Instruments [Table]",
"terseLabel": "Schedule of Long-term Debt Instruments [Table]"
}
}
},
"localname": "DebtInstrumentTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DeferredIncomeTaxExpenseBenefit": {
"auth_ref": [
"r104",
"r112",
"r307",
"r309"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 6.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
"label": "Deferred Income Tax Expense (Benefit)",
"terseLabel": "Deferred income taxes"
}
}
},
"localname": "DeferredIncomeTaxExpenseBenefit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredIncomeTaxesAndOtherAssetsCurrent": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 6.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and other assets expected to be realized or consumed within one year or normal operating cycle, if longer.",
"label": "Deferred Income Taxes and Other Assets, Current",
"terseLabel": "Deferred Income Taxes and Other Assets, Current"
}
}
},
"localname": "DeferredIncomeTaxesAndOtherAssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredRevenueArrangementTypeDomain": {
"auth_ref": [
"r21"
],
"lang": {
"en-US": {
"role": {
"documentation": "Category of obligation arising when an entity receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized.",
"label": "Deferred Revenue [Domain]",
"terseLabel": "Deferred Revenue [Domain]"
}
}
},
"localname": "DeferredRevenueArrangementTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DeferredRevenueCurrent": {
"auth_ref": [
"r38"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
"label": "Deferred Revenue, Current",
"terseLabel": "Deferred Revenue, Current"
}
}
},
"localname": "DeferredRevenueCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredRevenueRevenueRecognized1": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.",
"label": "Deferred Revenue, Revenue Recognized",
"terseLabel": "Deferred Revenue, Revenue Recognized"
}
}
},
"localname": "DeferredRevenueRevenueRecognized1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DeferredTaxAssetDomain": {
"auth_ref": [
"r306"
],
"lang": {
"en-US": {
"role": {
"documentation": "Identification of the deferred tax asset for which a valuation reserve exists.",
"label": "Deferred Tax Asset [Domain]",
"terseLabel": "Deferred Tax Asset [Domain]"
}
}
},
"localname": "DeferredTaxAssetDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Defined Benefit Plan [Abstract]",
"terseLabel": "Defined Benefit Plan and Postretirement Plan Disclosure"
}
}
},
"localname": "DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
"auth_ref": [
"r277",
"r278",
"r283",
"r293"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by defined benefit plan asset investment.",
"label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
"verboseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
}
}
},
"localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DefinedBenefitPlanDisclosureLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Defined Benefit Plan Disclosure [Line Items]",
"terseLabel": "Defined Benefit Plan Disclosures [Line Items]",
"verboseLabel": "Defined Benefit Plan Disclosure [Line Items]"
}
}
},
"localname": "DefinedBenefitPlanDisclosureLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
"auth_ref": [
"r282",
"r292",
"r293"
],
"calculation": {
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails": {
"order": 3.0,
"parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
"label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
"negatedLabel": "Expected return on plan assets"
}
}
},
"localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
"auth_ref": [
"r273",
"r276"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
"label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
"terseLabel": "Defined Benefit Plan, Funded (Unfunded) Status of Plan"
}
}
},
"localname": "DefinedBenefitPlanFundedStatusOfPlan",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DefinedBenefitPlanInterestCost": {
"auth_ref": [
"r275",
"r281",
"r291",
"r293"
],
"calculation": {
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails": {
"order": 2.0,
"parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
"label": "Defined Benefit Plan, Interest Cost",
"terseLabel": "Interest cost on benefit obligation"
}
}
},
"localname": "DefinedBenefitPlanInterestCost",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
"auth_ref": [
"r279",
"r289",
"r293"
],
"calculation": {
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
"label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
"terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
"totalLabel": "Defined benefit/postretirement plan costs"
}
}
},
"localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": {
"auth_ref": [
"r286",
"r293"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.",
"label": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
"terseLabel": "Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation"
}
}
},
"localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DefinedBenefitPlanServiceCost": {
"auth_ref": [
"r274",
"r280",
"r290",
"r293"
],
"calculation": {
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails": {
"order": 1.0,
"parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
"label": "Defined Benefit Plan, Service Cost",
"terseLabel": "Service cost for benefits earned"
}
}
},
"localname": "DefinedBenefitPlanServiceCost",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DefinedContributionPlanCostRecognized": {
"auth_ref": [
"r294"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cost for defined contribution plan.",
"label": "Defined Contribution Plan, Cost",
"negatedTerseLabel": "Defined contribution retirement plan cost",
"verboseLabel": "Defined Contribution Plan, Cost"
}
}
},
"localname": "DefinedContributionPlanCostRecognized",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage employer matches of the employee's percentage contribution matched.",
"label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
"terseLabel": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match"
}
}
},
"localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_DepreciationDepletionAndAmortization": {
"auth_ref": [
"r104",
"r147"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
"label": "Depreciation, Depletion and Amortization",
"terseLabel": "Depreciation and amortization"
}
}
},
"localname": "DepreciationDepletionAndAmortization",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeContractTypeDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
"label": "Derivative Contract [Domain]",
"terseLabel": "Derivative Contract Type [Domain]"
}
}
},
"localname": "DerivativeContractTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DerivativeInstrumentRiskAxis": {
"auth_ref": [
"r347",
"r348",
"r352",
"r355"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of derivative contract.",
"label": "Derivative Instrument [Axis]",
"terseLabel": "Derivative Instruments, Gain (Loss) by Derivative Instrument Risk [Axis]"
}
}
},
"localname": "DerivativeInstrumentRiskAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
}
}
},
"localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
"auth_ref": [
"r362"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
"label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
"terseLabel": "Derivative Instruments And Hedging Activities"
}
}
},
"localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivities"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
"auth_ref": [
"r344",
"r347",
"r352",
"r355",
"r356",
"r359",
"r361"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
"label": "Derivative Instruments, Gain (Loss) [Table]",
"terseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship [Table]"
}
}
},
"localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeInstrumentsGainLossLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Derivative Instruments, Gain (Loss) [Line Items]",
"terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
}
}
},
"localname": "DerivativeInstrumentsGainLossLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
"auth_ref": [
"r351",
"r354"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
"label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
"terseLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net"
}
}
},
"localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DerivativeNotionalAmount": {
"auth_ref": [
"r341",
"r343"
],
"lang": {
"en-US": {
"role": {
"documentation": "Nominal or face amount used to calculate payment on derivative.",
"label": "Derivative, Notional Amount",
"terseLabel": "Derivative, Notional Amount"
}
}
},
"localname": "DerivativeNotionalAmount",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DisaggregationOfRevenueLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Disaggregation of Revenue [Line Items]",
"terseLabel": "Disaggregation of Revenue [Line Items]"
}
}
},
"localname": "DisaggregationOfRevenueLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_DisaggregationOfRevenueTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
"label": "Disaggregation of Revenue [Table]",
"terseLabel": "Disaggregation of Revenue [Table]"
}
}
},
"localname": "DisaggregationOfRevenueTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_DisaggregationOfRevenueTableTextBlock": {
"auth_ref": [
"r261"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
"label": "Disaggregation of Revenue [Table Text Block]",
"terseLabel": "Disaggregation of Revenue [Table Text Block]"
}
}
},
"localname": "DisaggregationOfRevenueTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Discontinued Operations and Disposal Groups [Abstract]"
}
}
},
"localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_DisposalGroupClassificationAxis": {
"auth_ref": [
"r9"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by disposal group classification.",
"label": "Disposal Group Classification [Axis]",
"terseLabel": "Disposal Group Classification [Axis]"
}
}
},
"localname": "DisposalGroupClassificationAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_DisposalGroupClassificationDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
"label": "Disposal Group Classification [Domain]",
"terseLabel": "Disposal Group Classification [Domain]"
}
}
},
"localname": "DisposalGroupClassificationDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Name of disposal group.",
"label": "Disposal Group Name [Domain]",
"terseLabel": "Disposal Group Name [Domain]"
}
}
},
"localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_EarningsPerShareAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Earnings Per Share [Abstract]"
}
}
},
"localname": "EarningsPerShareAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_EarningsPerShareBasic": {
"auth_ref": [
"r82",
"r119",
"r125",
"r127",
"r128",
"r129",
"r132",
"r402",
"r414"
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
"label": "Earnings Per Share, Basic",
"terseLabel": "Basic earnings per common share (in dollars per share)"
}
}
},
"localname": "EarningsPerShareBasic",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"http://www.labcorp.com/role/EarningsPerShareReconciliationOfBasicEarningsPerShareToDilutedEarningsPerShareDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerShareDiluted": {
"auth_ref": [
"r82",
"r119",
"r125",
"r127",
"r128",
"r129",
"r132",
"r402",
"r414"
],
"lang": {
"en-US": {
"role": {
"documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
"label": "Earnings Per Share, Diluted",
"terseLabel": "Diluted earnings per common share (in dollars per share)"
}
}
},
"localname": "EarningsPerShareDiluted",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"http://www.labcorp.com/role/EarningsPerShareReconciliationOfBasicEarningsPerShareToDilutedEarningsPerShareDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerShareTextBlock": {
"auth_ref": [
"r133"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for earnings per share.",
"label": "Earnings Per Share [Text Block]",
"terseLabel": "Earnings Per Share"
}
}
},
"localname": "EarningsPerShareTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/EarningsPerShare"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
"auth_ref": [
"r375"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
"label": "Effect of Exchange Rate on Cash and Cash Equivalents",
"terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
}
}
},
"localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": {
"auth_ref": [
"r302",
"r303",
"r308"
],
"lang": {
"en-US": {
"role": {
"documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
"label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent",
"terseLabel": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent"
}
}
},
"localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/IncomeTaxesDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_EmployeeSeveranceMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
"label": "Employee Severance [Member]",
"terseLabel": "Employee Severance [Member]",
"verboseLabel": "Severance and Other Employee Costs [Member]"
}
}
},
"localname": "EmployeeSeveranceMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_EquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Equity [Abstract]"
}
}
},
"localname": "EquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_EquityComponentDomain": {
"auth_ref": [
"r245"
],
"lang": {
"en-US": {
"role": {
"documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
"label": "Equity Component [Domain]",
"terseLabel": "Equity Component [Domain]"
}
}
},
"localname": "EquityComponentDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquity",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_EquitySecuritiesFvNi": {
"auth_ref": [
"r371"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
"label": "Equity Securities, FV-NI",
"terseLabel": "Equity Securities, FV-NI"
}
}
},
"localname": "EquitySecuritiesFvNi",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FacilityClosingMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
"label": "Facility Closing [Member]",
"terseLabel": "Lease and Other Facility Costs [Member]",
"verboseLabel": "Facility Closing [Member]"
}
}
},
"localname": "FacilityClosingMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
"terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Financial Statement Captions [Line Items]"
}
}
},
"localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
"auth_ref": [
"r363",
"r364",
"r365",
"r370"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
"label": "Fair Value, Recurring and Nonrecurring [Table]",
"terseLabel": "Fair Value, Liabilities Measured on Recurring Basis [Table]"
}
}
},
"localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
"auth_ref": [
"r366",
"r370"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
"label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
"terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
}
}
},
"localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_FairValueByFairValueHierarchyLevelAxis": {
"auth_ref": [
"r277",
"r278",
"r293",
"r364",
"r389"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
"label": "Fair Value Hierarchy and NAV [Axis]",
"terseLabel": "Fair Value Hierarchy and NAV [Axis]",
"verboseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Axis]"
}
}
},
"localname": "FairValueByFairValueHierarchyLevelAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails",
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FairValueDisclosuresAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Fair Value Disclosures [Abstract]"
}
}
},
"localname": "FairValueDisclosuresAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_FairValueDisclosuresTextBlock": {
"auth_ref": [
"r368"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
"label": "Fair Value Disclosures [Text Block]",
"terseLabel": "Fair Value Measurements"
}
}
},
"localname": "FairValueDisclosuresTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurements"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_FairValueHedgeAssetsAtFairValue": {
"auth_ref": [
"r348"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of all derivative assets designated as fair value hedging instruments.",
"label": "Fair Value Hedge Assets",
"terseLabel": "Fair Value Hedge Assets"
}
}
},
"localname": "FairValueHedgeAssetsAtFairValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FairValueHedgeLiabilitiesAtFairValue": {
"auth_ref": [
"r348"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of all derivative liabilities designated as fair value hedging instruments.",
"label": "Fair Value Hedge Liabilities",
"negatedTerseLabel": "Fair Value Hedge Liabilities"
}
}
},
"localname": "FairValueHedgeLiabilitiesAtFairValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FairValueHedgesAtFairValueNet": {
"auth_ref": [
"r339"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Net fair value of all derivative instruments designated as fair value hedging instruments.",
"label": "Fair Value Hedges, Net",
"terseLabel": "Fair Value Hedges, Net"
}
}
},
"localname": "FairValueHedgesAtFairValueNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FairValueInputsLevel1Member": {
"auth_ref": [
"r277",
"r278",
"r293",
"r364",
"r390"
],
"lang": {
"en-US": {
"role": {
"documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
"label": "Fair Value, Inputs, Level 1 [Member]",
"terseLabel": "Level 1 [Member]"
}
}
},
"localname": "FairValueInputsLevel1Member",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueInputsLevel2Member": {
"auth_ref": [
"r277",
"r278",
"r293",
"r364",
"r391"
],
"lang": {
"en-US": {
"role": {
"documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
"label": "Fair Value, Inputs, Level 2 [Member]",
"terseLabel": "Fair Value, Inputs, Level 2 [Member]"
}
}
},
"localname": "FairValueInputsLevel2Member",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails",
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueInputsLevel3Member": {
"auth_ref": [
"r277",
"r278",
"r293",
"r364",
"r392"
],
"lang": {
"en-US": {
"role": {
"documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
"label": "Fair Value, Inputs, Level 3 [Member]",
"terseLabel": "Level 3 [Member]"
}
}
},
"localname": "FairValueInputsLevel3Member",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
"auth_ref": [
"r363",
"r364"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
"label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
"terseLabel": "Company's population of financial assets and liabilities subject to fair value measurements"
}
}
},
"localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/FairValueMeasurementsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
"label": "Fair Value Hierarchy and NAV [Domain]",
"terseLabel": "Fair Value Hierarchy and NAV [Domain]",
"verboseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Domain]"
}
}
},
"localname": "FairValueMeasurementsFairValueHierarchyDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails",
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss": {
"auth_ref": [
"r367",
"r369"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
"label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)",
"terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)"
}
}
},
"localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FinanceLeaseLiabilityCurrent": {
"auth_ref": [
"r386"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
"label": "Finance Lease, Liability, Current",
"terseLabel": "Finance Lease, Liability, Current"
}
}
},
"localname": "FinanceLeaseLiabilityCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/LeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FinanceLeaseLiabilityNoncurrent": {
"auth_ref": [
"r386"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
"label": "Finance Lease, Liability, Noncurrent",
"terseLabel": "Finance Lease, Liability, Noncurrent"
}
}
},
"localname": "FinanceLeaseLiabilityNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/LeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
"auth_ref": [
"r201"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Finite-Lived Intangible Assets, Accumulated Amortization",
"negatedTerseLabel": "Accumulated Amortization",
"terseLabel": "Finite-Lived Intangible Assets, Accumulated Amortization"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five",
"terseLabel": "Estimated amortization expense, Thereafter"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
"auth_ref": [
"r203"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months",
"terseLabel": "Estimated amortization expense, 2012"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
"auth_ref": [
"r203"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five",
"terseLabel": "Estimated amortization expense, 2016"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
"auth_ref": [
"r203"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
"terseLabel": "Estimated amortization expense, 2015"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
"auth_ref": [
"r203"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
"terseLabel": "Estimated amortization expense, 2014"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
"auth_ref": [
"r203"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
"label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
"terseLabel": "Estimated amortization expense, 2013"
}
}
},
"localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
"auth_ref": [
"r195",
"r198",
"r201",
"r205",
"r394"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by major type or class of finite-lived intangible assets.",
"label": "Finite-Lived Intangible Assets by Major Class [Axis]",
"terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
}
}
},
"localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
"terseLabel": "Finite-Lived Intangible Assets, Future Amortization Expense"
}
}
},
"localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Finite-Lived Intangible Assets [Line Items]",
"terseLabel": "Finite-Lived Intangible Assets [Line Items]"
}
}
},
"localname": "FiniteLivedIntangibleAssetsLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
"auth_ref": [
"r195",
"r200"
],
"lang": {
"en-US": {
"role": {
"documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
"label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
"terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
}
}
},
"localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_FinitelivedIntangibleAssetsAcquired1": {
"auth_ref": [
"r196"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
"label": "Finite-lived Intangible Assets Acquired",
"terseLabel": "Finite-lived Intangible Assets Acquired"
}
}
},
"localname": "FinitelivedIntangibleAssetsAcquired1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.",
"label": "Foreign Currency Contract, Asset, Fair Value Disclosure",
"terseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure"
}
}
},
"localname": "ForeignCurrencyContractAssetFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails",
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
"label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
"terseLabel": "Foreign Currency Contracts, Liability, Fair Value Disclosure"
}
}
},
"localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GainLossOnDispositionOfAssets1": {
"auth_ref": [
"r104"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 16.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
"label": "Gain (Loss) on Disposition of Assets",
"negatedTerseLabel": "Gain (Loss) on Disposition of Assets",
"terseLabel": "Gain (Loss) on Disposition of Assets"
}
}
},
"localname": "GainLossOnDispositionOfAssets1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_Goodwill": {
"auth_ref": [
"r183",
"r185"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
"label": "Goodwill",
"netLabel": "Goodwill, net",
"periodEndLabel": "Balance at end of period",
"periodStartLabel": "Balance as of January 1",
"terseLabel": "Goodwill",
"verboseLabel": "Goodwill"
}
}
},
"localname": "Goodwill",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GoodwillAcquiredDuringPeriod": {
"auth_ref": [
"r186"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
"label": "Goodwill, Acquired During Period",
"terseLabel": "Goodwill, Acquired During Period"
}
}
},
"localname": "GoodwillAcquiredDuringPeriod",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GoodwillAndIntangibleAssetImpairment": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
"label": "Goodwill and Intangible Asset Impairment",
"terseLabel": "Goodwill and Intangible Asset Impairment"
}
}
},
"localname": "GoodwillAndIntangibleAssetImpairment",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Goodwill and Intangible Assets Disclosure [Abstract]"
}
}
},
"localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
"auth_ref": [
"r207"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for goodwill and intangible assets.",
"label": "Goodwill and Intangible Assets Disclosure [Text Block]",
"terseLabel": "Goodwill and Intangible Assets"
}
}
},
"localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssets"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_GoodwillImpairmentLoss": {
"auth_ref": [
"r104",
"r184",
"r187",
"r191"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
"label": "Goodwill, Impairment Loss",
"terseLabel": "Goodwill, Impairment Loss"
}
}
},
"localname": "GoodwillImpairmentLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GoodwillLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Goodwill [Line Items]",
"terseLabel": "Goodwill [Line Items]"
}
}
},
"localname": "GoodwillLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_GoodwillMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
"label": "Goodwill [Member]",
"terseLabel": "Goodwill [Member]"
}
}
},
"localname": "GoodwillMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_GoodwillRollForward": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
"label": "Goodwill [Roll Forward]",
"terseLabel": "Goodwill [Roll Forward]"
}
}
},
"localname": "GoodwillRollForward",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
"auth_ref": [
"r188",
"r189",
"r314"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
"label": "Goodwill, Translation and Purchase Accounting Adjustments",
"terseLabel": "Adjustments to goodwill"
}
}
},
"localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GrossProfit": {
"auth_ref": [
"r84"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
"label": "Gross Profit",
"totalLabel": "Gross Profit"
}
}
},
"localname": "GrossProfit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
"auth_ref": [
"r104",
"r206"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
"label": "Impairment of Intangible Assets (Excluding Goodwill)",
"terseLabel": "Impairment of Intangible Assets (Excluding Goodwill)"
}
}
},
"localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ImpairmentOfInvestments": {
"auth_ref": [
"r167"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
"label": "Other than Temporary Impairment Losses, Investments",
"terseLabel": "Other than Temporary Impairment Losses, Investments"
}
}
},
"localname": "ImpairmentOfInvestments",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeLossFromEquityMethodInvestments": {
"auth_ref": [
"r80",
"r104",
"r148",
"r168",
"r400",
"r412"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 3.0,
"parentTag": "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
"label": "Income (Loss) from Equity Method Investments",
"terseLabel": "Equity method income, net"
}
}
},
"localname": "IncomeLossFromEquityMethodInvestments",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeStatementAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Income Statement [Abstract]"
}
}
},
"localname": "IncomeStatementAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by name of disposal group.",
"label": "Disposal Group Name [Axis]",
"terseLabel": "Disposal Group Name [Axis]"
}
}
},
"localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
"terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
}
}
},
"localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
"auth_ref": [
"r0",
"r2",
"r3",
"r4",
"r5",
"r6",
"r7",
"r8",
"r10",
"r11",
"r12",
"r213",
"r214"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
"label": "Disposal Groups, Including Discontinued Operations [Table]",
"terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
}
}
},
"localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncomeStatementLocationAxis": {
"auth_ref": [
"r211"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by location in the income statement.",
"label": "Income Statement Location [Axis]",
"terseLabel": "Income Statement Location [Axis]"
}
}
},
"localname": "IncomeStatementLocationAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncomeStatementLocationDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Location in the income statement.",
"label": "Income Statement Location [Domain]",
"terseLabel": "Income Statement Location [Domain]"
}
}
},
"localname": "IncomeStatementLocationDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_IncomeTaxDisclosureAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Income Tax Disclosure [Abstract]"
}
}
},
"localname": "IncomeTaxDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxDisclosureTextBlock": {
"auth_ref": [
"r313"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
"label": "Income Tax Disclosure [Text Block]",
"terseLabel": "Income Taxes"
}
}
},
"localname": "IncomeTaxDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/IncomeTaxes"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_IncomeTaxExpenseBenefit": {
"auth_ref": [
"r112",
"r149",
"r311"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_ProfitLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
"label": "Income Tax Expense (Benefit)",
"terseLabel": "Provision for income taxes"
}
}
},
"localname": "IncomeTaxExpenseBenefit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeTaxesPaidNet": {
"auth_ref": [
"r107"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
"label": "Income Taxes Paid, Net",
"terseLabel": "Income taxes, net of refunds"
}
}
},
"localname": "IncomeTaxesPaidNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccountsPayable": {
"auth_ref": [
"r103"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 12.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
"label": "Increase (Decrease) in Accounts Payable",
"terseLabel": "Decrease in accounts payable"
}
}
},
"localname": "IncreaseDecreaseInAccountsPayable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccountsReceivable": {
"auth_ref": [
"r103"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 8.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
"label": "Increase (Decrease) in Accounts Receivable",
"negatedTerseLabel": "Increase in accounts receivable (net)"
}
}
},
"localname": "IncreaseDecreaseInAccountsReceivable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
"auth_ref": [
"r103"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 14.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
"label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
"terseLabel": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities"
}
}
},
"localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInDeferredRevenue": {
"auth_ref": [
"r103"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 13.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
"label": "Increase (Decrease) in Deferred Revenue",
"terseLabel": "Increase (Decrease) in Deferred Revenue"
}
}
},
"localname": "IncreaseDecreaseInDeferredRevenue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInInventories": {
"auth_ref": [
"r103"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 10.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
"label": "Increase (Decrease) in Inventories",
"negatedTerseLabel": "Increase in inventories"
}
}
},
"localname": "IncreaseDecreaseInInventories",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Increase (Decrease) in Operating Capital [Abstract]",
"terseLabel": "Change in assets and liabilities (net of effects of acquisitions):"
}
}
},
"localname": "IncreaseDecreaseInOperatingCapitalAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
"auth_ref": [
"r103"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 11.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
"label": "Increase (Decrease) in Prepaid Expense and Other Assets",
"negatedTerseLabel": "Decrease in prepaid expenses and other"
}
}
},
"localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
"auth_ref": [
"r126",
"r131"
],
"lang": {
"en-US": {
"role": {
"documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
"label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
"terseLabel": "Dilutive effect of employee stock options and awards, (in shares)"
}
}
},
"localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/EarningsPerShareReconciliationOfBasicEarningsPerShareToDilutedEarningsPerShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_IndefiniteLivedTradeNames": {
"auth_ref": [
"r204"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.",
"label": "Indefinite-Lived Trade Names",
"terseLabel": "Indefinite-Lived Trade Names"
}
}
},
"localname": "IndefiniteLivedTradeNames",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
"auth_ref": [
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
"label": "Intangible Assets, Gross (Excluding Goodwill)",
"terseLabel": "Intangible Assets, Gross (Excluding Goodwill)"
}
}
},
"localname": "IntangibleAssetsGrossExcludingGoodwill",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IntangibleAssetsNetExcludingGoodwill": {
"auth_ref": [
"r193",
"r199"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
"label": "Intangible Assets, Net (Excluding Goodwill)",
"terseLabel": "Intangible Assets, Net (Excluding Goodwill)",
"verboseLabel": "Intangible Assets, Net (Excluding Goodwill)"
}
}
},
"localname": "IntangibleAssetsNetExcludingGoodwill",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestExpense": {
"auth_ref": [
"r78",
"r146",
"r380",
"r383",
"r403"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 2.0,
"parentTag": "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
"label": "Interest Expense",
"negatedTerseLabel": "Interest expense"
}
}
},
"localname": "InterestExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestRateSwapMember": {
"auth_ref": [
"r353"
],
"lang": {
"en-US": {
"role": {
"documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
"label": "Interest Rate Swap [Member]",
"terseLabel": "Interest Rate Swap [Member]"
}
}
},
"localname": "InterestRateSwapMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_InventoriesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tangible personal property held for sale in the ordinary course of business, or in process of, or to be consumed in, production for sale.",
"label": "Inventories [Member]",
"terseLabel": "Inventories [Member]"
}
}
},
"localname": "InventoriesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_InventoryNet": {
"auth_ref": [
"r15",
"r60",
"r177"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
"label": "Inventory, Net",
"terseLabel": "Supplies inventories"
}
}
},
"localname": "InventoryNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InvestmentIncomeNet": {
"auth_ref": [
"r89",
"r91",
"r92"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 4.0,
"parentTag": "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
"label": "Investment Income, Net",
"terseLabel": "Investment income"
}
}
},
"localname": "InvestmentIncomeNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
"auth_ref": [
"r41"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
"label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
"terseLabel": "Joint venture partnerships and equity method investments"
}
}
},
"localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LeasesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Leases [Abstract]"
}
}
},
"localname": "LeasesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_Liabilities": {
"auth_ref": [
"r47"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
"label": "Liabilities",
"totalLabel": "Noncontrolling interest"
}
}
},
"localname": "Liabilities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquity": {
"auth_ref": [
"r37",
"r399",
"r410"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
"label": "Liabilities and Equity",
"terseLabel": "Liabilities and Equity",
"totalLabel": "Liabilities and Equity"
}
}
},
"localname": "LiabilitiesAndStockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Liabilities and Equity [Abstract]",
"terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY"
}
}
},
"localname": "LiabilitiesAndStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesCurrent": {
"auth_ref": [
"r49"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
"label": "Liabilities, Current",
"terseLabel": "Long-term debt, less current portion"
}
}
},
"localname": "LiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesCurrentAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Liabilities, Current [Abstract]",
"terseLabel": "Liabilities, Current [Abstract]"
}
}
},
"localname": "LiabilitiesCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilityMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
"label": "Liability [Member]",
"terseLabel": "Liability [Member]"
}
}
},
"localname": "LiabilityMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_LicensingAgreementsMember": {
"auth_ref": [
"r325"
],
"lang": {
"en-US": {
"role": {
"documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
"label": "Licensing Agreements [Member]",
"terseLabel": "Canadian licenses [Member]"
}
}
},
"localname": "LicensingAgreementsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_LineOfCreditFacilityAxis": {
"auth_ref": [
"r44",
"r114"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
"label": "Lender Name [Axis]",
"terseLabel": "Lender Name [Axis]"
}
}
},
"localname": "LineOfCreditFacilityAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
"auth_ref": [
"r373"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value of the amount outstanding under the credit facility.",
"label": "Line of Credit Facility, Fair Value of Amount Outstanding",
"terseLabel": "Line of Credit Facility, Fair Value of Amount Outstanding"
}
}
},
"localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
"auth_ref": [
"r44"
],
"lang": {
"en-US": {
"role": {
"documentation": "The effective interest rate at the end of the reporting period.",
"label": "Line of Credit Facility, Interest Rate at Period End",
"terseLabel": "Line of Credit Facility, Interest Rate at Period End"
}
}
},
"localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails"
],
"xbrltype": "percentItemType"
},
"us-gaap_LineOfCreditFacilityInterestRateDescription": {
"auth_ref": [
"r44"
],
"lang": {
"en-US": {
"role": {
"documentation": "Description of the interest rate for the amounts borrowed under the credit facility, including the terms and the method for determining the interest rate (for example, fixed or variable, LIBOR plus a percentage, increasing rate, timing of interest rate resets, remarketing provisions).",
"label": "Line of Credit Facility, Interest Rate Description",
"terseLabel": "Line of Credit Facility, Interest Rate Description"
}
}
},
"localname": "LineOfCreditFacilityInterestRateDescription",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LineOfCreditFacilityLenderDomain": {
"auth_ref": [
"r44"
],
"lang": {
"en-US": {
"role": {
"documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
"label": "Line of Credit Facility, Lender [Domain]",
"terseLabel": "Line of Credit Facility, Lender [Domain]"
}
}
},
"localname": "LineOfCreditFacilityLenderDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/FairValueMeasurementsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_LineOfCreditFacilityLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Line of Credit Facility [Line Items]",
"terseLabel": "Line of Credit Facility [Line Items]"
}
}
},
"localname": "LineOfCreditFacilityLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
"auth_ref": [
"r44"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
"label": "Line of Credit Facility, Maximum Borrowing Capacity",
"terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity",
"verboseLabel": "Revolving Credit Facility, maximum borrowing capacity"
}
}
},
"localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
"auth_ref": [
"r44"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
"label": "Line of Credit Facility, Remaining Borrowing Capacity",
"terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
}
}
},
"localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LineOfCreditFacilityTable": {
"auth_ref": [
"r44",
"r114"
],
"lang": {
"en-US": {
"role": {
"documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
"label": "Line of Credit Facility [Table]",
"terseLabel": "Line of Credit Facility [Table]"
}
}
},
"localname": "LineOfCreditFacilityTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LondonInterbankOfferedRateLIBORMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
"label": "London Interbank Offered Rate (LIBOR) [Member]",
"terseLabel": "London Interbank Offered Rate (LIBOR) [Member]"
}
}
},
"localname": "LondonInterbankOfferedRateLIBORMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_LongTermDebtNoncurrent": {
"auth_ref": [
"r51"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
"label": "Long-term Debt, Excluding Current Maturities",
"terseLabel": "Long-term Debt, Excluding Current Maturities"
}
}
},
"localname": "LongTermDebtNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LongtermDebtTypeAxis": {
"auth_ref": [
"r51"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of long-term debt.",
"label": "Long-term Debt, Type [Axis]",
"terseLabel": "Long-term Debt, Type [Axis]"
}
}
},
"localname": "LongtermDebtTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LongtermDebtTypeDomain": {
"auth_ref": [
"r51",
"r239"
],
"lang": {
"en-US": {
"role": {
"documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
"label": "Long-term Debt, Type [Domain]",
"terseLabel": "Long-term Debt, Type [Domain]"
}
}
},
"localname": "LongtermDebtTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_LossContingenciesLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Loss Contingencies [Line Items]",
"terseLabel": "Loss Contingencies [Line Items]"
}
}
},
"localname": "LossContingenciesLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_LossContingenciesTable": {
"auth_ref": [
"r229",
"r230",
"r231",
"r232",
"r233",
"r234",
"r235",
"r237",
"r238"
],
"lang": {
"en-US": {
"role": {
"documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
"label": "Loss Contingencies [Table]",
"terseLabel": "Loss Contingencies [Table]"
}
}
},
"localname": "LossContingenciesTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CommitmentsAndContingenciesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_MinorityInterestLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Noncontrolling Interest [Line Items]",
"terseLabel": "Noncontrolling Interest [Line Items]"
}
}
},
"localname": "MinorityInterestLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/NoncontrollingInterestPutsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_MinorityInterestTable": {
"auth_ref": [
"r59",
"r85",
"r329",
"r335"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
"label": "Noncontrolling Interest [Table]",
"terseLabel": "Noncontrolling Interest [Table]"
}
}
},
"localname": "MinorityInterestTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/NoncontrollingInterestPutsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivities": {
"auth_ref": [
"r101"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
"label": "Net Cash Provided by (Used in) Financing Activities",
"terseLabel": "Net Cash Provided by (Used in) Financing Activities",
"totalLabel": "Net cash provided by (used for) financing activities"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
"terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivities": {
"auth_ref": [
"r101"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
"label": "Net Cash Provided by (Used in) Investing Activities",
"terseLabel": "Net Cash Provided by (Used in) Investing Activities",
"totalLabel": "Net cash used for investing activities"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
"terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivities": {
"auth_ref": [
"r101",
"r102",
"r105"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
"weight": 1.0
}
},
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
"label": "Net Cash Provided by (Used in) Operating Activities",
"terseLabel": "Net Cash Provided by (Used in) Operating Activities",
"totalLabel": "Net cash provided by operating activities"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivities",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
"terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetIncomeLoss": {
"auth_ref": [
"r71",
"r74",
"r81",
"r105",
"r131",
"r401",
"r413"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
"label": "Net Income (Loss) Attributable to Parent",
"netLabel": "Net Income (Loss) Attributable to Parent",
"terseLabel": "Net Income (Loss) Attributable to Parent",
"totalLabel": "Net earnings attributable to Laboratory Corporation of America Holdings",
"verboseLabel": "Net earnings attributable to Laboratory Corporation of America Holdings"
}
}
},
"localname": "NetIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"http://www.labcorp.com/role/EarningsPerShareReconciliationOfBasicEarningsPerShareToDilutedEarningsPerShareDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
"auth_ref": [
"r71",
"r74",
"r332",
"r336"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
"weight": -1.0
},
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
"label": "Net Income (Loss) Attributable to Noncontrolling Interest",
"negatedLabel": "Less: Net earnings attributable to the noncontrolling interest",
"negatedTerseLabel": "Net income attributable to Laboratory Corporation of America Holdings"
}
}
},
"localname": "NetIncomeLossAttributableToNoncontrollingInterest",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
"auth_ref": [
"r123",
"r124"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
"label": "Net Income (Loss) Available to Common Stockholders, Diluted",
"terseLabel": "Net Income (Loss) Available to Common Stockholders, Diluted"
}
}
},
"localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/EarningsPerShareReconciliationOfBasicEarningsPerShareToDilutedEarningsPerShareDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1": {
"auth_ref": [
"r118",
"r120"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cumulative effect of the change in accounting principle or new accounting pronouncement on retained earnings or other components of equity or net assets in the statement of financial position as of the beginning of the earliest period presented.",
"label": "New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets",
"terseLabel": "New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets",
"verboseLabel": "New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification"
}
}
},
"localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
"label": "New Accounting Pronouncements, Policy [Policy Text Block]",
"terseLabel": "New Accounting Pronouncements, Policy [Policy Text Block]"
}
}
},
"localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationNewAccountingPronouncementsPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_NoncompeteAgreementsMember": {
"auth_ref": [
"r323"
],
"lang": {
"en-US": {
"role": {
"documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
"label": "Noncompete Agreements [Member]",
"terseLabel": "Noncompete Agreements [Member]"
}
}
},
"localname": "NoncompeteAgreementsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_NonoperatingIncomeExpense": {
"auth_ref": [
"r90"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
"label": "Nonoperating Income (Expense)",
"terseLabel": "Nonoperating Income (Expense)"
}
}
},
"localname": "NonoperatingIncomeExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NonoperatingIncomeExpenseAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Nonoperating Income (Expense) [Abstract]",
"terseLabel": "Other income (expenses):"
}
}
},
"localname": "NonoperatingIncomeExpenseAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NonrecurringAdjustmentAxis": {
"auth_ref": [
"r317"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information about material and nonrecurring adjustment directly attributable to the business combination(s) included in the reported pro forma revenue and earnings (supplemental pro forma information).",
"label": "Nonrecurring Adjustment [Axis]",
"terseLabel": "Nonrecurring Adjustment [Axis]"
}
}
},
"localname": "NonrecurringAdjustmentAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_NonrecurringAdjustmentDomain": {
"auth_ref": [
"r317"
],
"lang": {
"en-US": {
"role": {
"documentation": "Material, nonrecurring adjustment(s) allocated (included) to (in) reported pro forma revenue and earnings (supplemental pro forma information).",
"label": "Nonrecurring Adjustment [Domain]",
"terseLabel": "Nonrecurring Adjustment [Domain]"
}
}
},
"localname": "NonrecurringAdjustmentDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_NotesPayable": {
"auth_ref": [
"r27",
"r398",
"r408"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.",
"label": "Notes Payable",
"terseLabel": "Notes Payable"
}
}
},
"localname": "NotesPayable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NotesPayableCurrent": {
"auth_ref": [
"r46"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
"label": "Notes Payable, Current",
"terseLabel": "Notes Payable"
}
}
},
"localname": "NotesPayableCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NotesReceivableFairValueDisclosure": {
"auth_ref": [
"r56"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.",
"label": "Notes Receivable, Fair Value Disclosure",
"terseLabel": "Notes Receivable, Fair Value Disclosure"
}
}
},
"localname": "NotesReceivableFairValueDisclosure",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/FairValueMeasurementsDetails",
"http://www.labcorp.com/role/SupplementalCashFlowInformationDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NotesReceivableMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
"label": "Notes Receivable [Member]",
"terseLabel": "Notes Receivable [Member]"
}
}
},
"localname": "NotesReceivableMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OperatingIncomeLoss": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 1.0,
"parentTag": "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The net result for the period of deducting operating expenses from operating revenues.",
"label": "Operating Income (Loss)",
"terseLabel": "Operating Income (Loss)",
"totalLabel": "Operating Income (Loss)"
}
}
},
"localname": "OperatingIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeaseImpairmentLoss": {
"auth_ref": [
"r385"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
"label": "Operating Lease, Impairment Loss",
"terseLabel": "Operating Lease, Impairment Loss"
}
}
},
"localname": "OperatingLeaseImpairmentLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeaseLiabilityCurrent": {
"auth_ref": [
"r386"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
"label": "Operating Lease, Liability, Current",
"terseLabel": "Operating Lease, Liability, Current"
}
}
},
"localname": "OperatingLeaseLiabilityCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/LeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingLeaseLiabilityNoncurrent": {
"auth_ref": [
"r386"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
"label": "Operating Lease, Liability, Noncurrent",
"terseLabel": "Operating Lease, Liability, Noncurrent"
}
}
},
"localname": "OperatingLeaseLiabilityNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/LeasesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
"auth_ref": [
"r13",
"r117",
"r141",
"r338"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
"label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
"terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]"
}
}
},
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentation"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
"auth_ref": [
"r117",
"r121",
"r141",
"r338"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
"label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
"terseLabel": "Basis of Presentation and Significant Accounting Policies [Text Block]"
}
}
},
"localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentation"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_OtherAssetImpairmentCharges": {
"auth_ref": [
"r104",
"r210"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.",
"label": "Other Asset Impairment Charges",
"terseLabel": "Other Asset Impairment Charges"
}
}
},
"localname": "OtherAssetImpairmentCharges",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherAssetsNoncurrent": {
"auth_ref": [
"r42"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 7.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of noncurrent assets classified as other.",
"label": "Other Assets, Noncurrent",
"terseLabel": "Other assets, net"
}
}
},
"localname": "OtherAssetsNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
"auth_ref": [
"r62",
"r66",
"r374",
"r376",
"r377"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
"label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
"terseLabel": "Other comprehensive income before reclassifications",
"verboseLabel": "Other comprehensive income before reclassifications"
}
}
},
"localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLocationAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by location in other comprehensive income.",
"label": "Other Comprehensive Income Location [Axis]",
"terseLabel": "Other Comprehensive Income Location [Axis]"
}
}
},
"localname": "OtherComprehensiveIncomeLocationAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_OtherComprehensiveIncomeLocationDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Location in other comprehensive income.",
"label": "Other Comprehensive Income Location [Domain]",
"terseLabel": "Other Comprehensive Income Location [Domain]"
}
}
},
"localname": "OtherComprehensiveIncomeLocationDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables"
],
"xbrltype": "domainItemType"
},
"us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
"auth_ref": [
"r69"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
"label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
"terseLabel": "Other Comprehensive Income (Loss), before Reclassifications, before Tax"
}
}
},
"localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
"auth_ref": [
"r169"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
"label": "Other Comprehensive Income (Loss), before Tax",
"totalLabel": "Other comprehensive earnings (loss) before tax"
}
}
},
"localname": "OtherComprehensiveIncomeLossBeforeTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": {
"auth_ref": [
"r62",
"r66",
"r374",
"r378"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
"label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax",
"terseLabel": "Foreign currency translation adjustments"
}
}
},
"localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
"auth_ref": [
"r72",
"r75",
"r77",
"r245"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
"label": "Other Comprehensive Income (Loss), Net of Tax",
"terseLabel": "Other comprehensive earnings, net of tax",
"totalLabel": "Other comprehensive earnings (loss), net of tax"
}
}
},
"localname": "OtherComprehensiveIncomeLossNetOfTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
"verboseLabel": "Other Comprehensive Earnings, Net of Tax"
}
}
},
"localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax": {
"auth_ref": [
"r64",
"r66"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, before tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
"label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax",
"terseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax"
}
}
},
"localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
"auth_ref": [
"r64",
"r66"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
"label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
"negatedTerseLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax"
}
}
},
"localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
"auth_ref": [
"r64",
"r67",
"r330"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
"label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
"negatedTerseLabel": "Tax effect of adjustments"
}
}
},
"localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeLossTax": {
"auth_ref": [
"r67",
"r310",
"r312"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
"label": "Other Comprehensive Income (Loss), Tax",
"negatedTerseLabel": "Tax effect of adjustments"
}
}
},
"localname": "OtherComprehensiveIncomeLossTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax": {
"auth_ref": [
"r63",
"r67"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of tax expense (benefit), before reclassification adjustments, related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
"label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax",
"negatedTerseLabel": "Tax effect of adjustments"
}
}
},
"localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherCurrentAssetsMember": {
"auth_ref": [
"r346",
"r359"
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing other current assets.",
"label": "Other Current Assets [Member]",
"terseLabel": "Other Current Assets [Member]"
}
}
},
"localname": "OtherCurrentAssetsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OtherLiabilitiesMember": {
"auth_ref": [
"r346",
"r359"
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing other liabilities.",
"label": "Other Liabilities [Member]",
"terseLabel": "Other Liabilities [Member]"
}
}
},
"localname": "OtherLiabilitiesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OtherLiabilitiesNoncurrent": {
"auth_ref": [
"r52"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 6.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
"label": "Other Liabilities, Noncurrent",
"terseLabel": "Commitments and contingent liabilities"
}
}
},
"localname": "OtherLiabilitiesNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherNoncurrentAssetsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing other noncurrent assets.",
"label": "Other Noncurrent Assets [Member]",
"terseLabel": "Other Noncurrent Assets [Member]"
}
}
},
"localname": "OtherNoncurrentAssetsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OtherNoncurrentLiabilitiesMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
"label": "Other Noncurrent Liabilities [Member]",
"terseLabel": "Other Noncurrent Liabilities [Member]"
}
}
},
"localname": "OtherNoncurrentLiabilitiesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OtherNonoperatingIncomeExpense": {
"auth_ref": [
"r92"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 5.0,
"parentTag": "lh_IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
"label": "Other Nonoperating Income (Expense)",
"terseLabel": "Other, net"
}
}
},
"localname": "OtherNonoperatingIncomeExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OtherNonoperatingIncomeExpenseMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
"label": "Other Nonoperating Income (Expense) [Member]",
"terseLabel": "Other Nonoperating Income (Expense) [Member]"
}
}
},
"localname": "OtherNonoperatingIncomeExpenseMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_OtherOperatingActivitiesCashFlowStatement": {
"auth_ref": [
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 7.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
"label": "Other Operating Activities, Cash Flow Statement",
"terseLabel": "Other Operating Activities, Cash Flow Statement"
}
}
},
"localname": "OtherOperatingActivitiesCashFlowStatement",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsForRepurchaseOfCommonStock": {
"auth_ref": [
"r98"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow to reacquire common stock during the period.",
"label": "Payments for Repurchase of Common Stock",
"negatedTerseLabel": "Payments for Repurchase of Common Stock",
"terseLabel": "Payments for Repurchase of Common Stock"
}
}
},
"localname": "PaymentsForRepurchaseOfCommonStock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
"auth_ref": [
"r98"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
"label": "Payment, Tax Withholding, Share-based Payment Arrangement",
"negatedTerseLabel": "Payment, Tax Withholding, Share-based Payment Arrangement"
}
}
},
"localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
"auth_ref": [
"r95"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
"label": "Payments to Acquire Businesses, Net of Cash Acquired",
"negatedLabel": "Acquisition of businesses, net of cash acquired",
"terseLabel": "Payments to Acquire Businesses, Net of Cash Acquired"
}
}
},
"localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquireEquityMethodInvestments": {
"auth_ref": [
"r95"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
"label": "Payments to Acquire Equity Method Investments",
"negatedTerseLabel": "Investments in equity affiliates"
}
}
},
"localname": "PaymentsToAcquireEquityMethodInvestments",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
"auth_ref": [
"r96"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
"label": "Payments to Acquire Property, Plant, and Equipment",
"negatedLabel": "Capital expenditures",
"terseLabel": "Cash payments for laboratory-related assets"
}
}
},
"localname": "PaymentsToAcquirePropertyPlantAndEquipment",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
"auth_ref": [
"r295"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for pension and other postretirement benefits.",
"label": "Pension and Other Postretirement Benefits Disclosure [Text Block]",
"terseLabel": "Pension And Postretirement Plans"
}
}
},
"localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlans",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_PensionAndOtherPostretirementPlansCostsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Rate action of a regulator resulting in capitalization or accrual of pension and other postretirement costs.",
"label": "Pension and Other Postretirement Plans Costs [Member]",
"terseLabel": "Pension and Other Postretirement Plans Costs [Member]"
}
}
},
"localname": "PensionAndOtherPostretirementPlansCostsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PensionPlansDefinedBenefitMember": {
"auth_ref": [
"r271",
"r284",
"r285",
"r294"
],
"lang": {
"en-US": {
"role": {
"documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
"label": "Pension Plan [Member]",
"terseLabel": "Pension Plan [Member]"
}
}
},
"localname": "PensionPlansDefinedBenefitMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PlanAssetCategoriesDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Defined benefit plan asset investment.",
"label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
"terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
}
}
},
"localname": "PlanAssetCategoriesDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PostemploymentBenefitsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Postemployment Benefits [Abstract]"
}
}
},
"localname": "PostemploymentBenefitsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_PreferredStockParOrStatedValuePerShare": {
"auth_ref": [
"r30"
],
"lang": {
"en-US": {
"role": {
"documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
"label": "Preferred Stock, Par or Stated Value Per Share",
"terseLabel": "Preferred Stock, Par or Stated Value Per Share"
}
}
},
"localname": "PreferredStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_PreferredStockSharesAuthorized": {
"auth_ref": [
"r30"
],
"lang": {
"en-US": {
"role": {
"documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
"label": "Preferred Stock, Shares Authorized",
"terseLabel": "Preferred Stock, Shares Authorized"
}
}
},
"localname": "PreferredStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesOutstanding": {
"auth_ref": [
"r30"
],
"lang": {
"en-US": {
"role": {
"documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
"label": "Preferred Stock, Shares Outstanding",
"terseLabel": "Preferred Stock, Shares Outstanding"
}
}
},
"localname": "PreferredStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PrepaidExpenseCurrent": {
"auth_ref": [
"r17",
"r19",
"r178"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 5.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
"label": "Prepaid Expense, Current",
"terseLabel": "Prepaid expenses and other"
}
}
},
"localname": "PrepaidExpenseCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
"label": "Prepaid Expenses and Other Current Assets [Member]",
"terseLabel": "Prepaid Expenses and Other Current Assets [Member]"
}
}
},
"localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PrimeRateMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
"label": "Prime Rate [Member]",
"terseLabel": "Prime Rate [Member]"
}
}
},
"localname": "PrimeRateMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ProceedsFromLongTermLinesOfCredit": {
"auth_ref": [
"r97"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
"label": "Proceeds from Long-term Lines of Credit",
"terseLabel": "Proceeds from revolving credit facilities"
}
}
},
"localname": "ProceedsFromLongTermLinesOfCredit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromSaleOfEquityMethodInvestments": {
"auth_ref": [
"r93"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
"label": "Proceeds from Sale of Equity Method Investments",
"terseLabel": "Proceeds from Sale of Equity Method Investments"
}
}
},
"localname": "ProceedsFromSaleOfEquityMethodInvestments",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
"auth_ref": [
"r94"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
"label": "Proceeds from Sale of Property, Plant, and Equipment",
"terseLabel": "Proceeds from sale of assets"
}
}
},
"localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProfitLoss": {
"auth_ref": [
"r71",
"r74",
"r100",
"r150",
"r157",
"r330",
"r331",
"r333",
"r336",
"r337"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
},
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
"weight": 1.0
},
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
"label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
"terseLabel": "Net earnings",
"totalLabel": "Net earnings"
}
}
},
"localname": "ProfitLoss",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PropertyPlantAndEquipmentMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
"label": "Property, Plant and Equipment [Member]",
"terseLabel": "Property, Plant and Equipment [Member]"
}
}
},
"localname": "PropertyPlantAndEquipmentMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_PropertyPlantAndEquipmentNet": {
"auth_ref": [
"r23",
"r24",
"r209",
"r411"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
"label": "Property, Plant and Equipment, Net",
"terseLabel": "Property, plant and equipment, net"
}
}
},
"localname": "PropertyPlantAndEquipmentNet",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProspectiveAdoptionOfNewAccountingPronouncementsAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information related to prospectively adopted accounting guidance.",
"label": "Prospective Adoption of New Accounting Pronouncements [Axis]",
"terseLabel": "Prospective Adoption of New Accounting Pronouncements [Axis]"
}
}
},
"localname": "ProspectiveAdoptionOfNewAccountingPronouncementsAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_ProvisionForDoubtfulAccounts": {
"auth_ref": [
"r83",
"r173"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
"label": "Accounts Receivable, Credit Loss Expense (Reversal)",
"terseLabel": "Accounts Receivable, Credit Loss Expense (Reversal)"
}
}
},
"localname": "ProvisionForDoubtfulAccounts",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
"auth_ref": [
"r152",
"r154"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
"label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
"terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]"
}
}
},
"localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessSegmentInformationTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RepaymentsOfLinesOfCredit": {
"auth_ref": [
"r99",
"r115"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
"label": "Repayments of Lines of Credit",
"negatedTerseLabel": "Repayments of Lines of Credit"
}
}
},
"localname": "RepaymentsOfLinesOfCredit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RestructuringAndRelatedActivitiesAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Restructuring and Related Activities [Abstract]"
}
}
},
"localname": "RestructuringAndRelatedActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
"auth_ref": [
"r227"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
"label": "Restructuring and Related Activities Disclosure [Text Block]",
"terseLabel": "Restructuring and Related Activities Disclosure [Text Block]"
}
}
},
"localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialCharges"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RestructuringCharges": {
"auth_ref": [
"r104",
"r215",
"r220",
"r225"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
"label": "Restructuring Charges",
"terseLabel": "Restructuring charges",
"verboseLabel": "Restructuring Charges"
}
}
},
"localname": "RestructuringCharges",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RestructuringCostAndReserveAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of restructuring cost.",
"label": "Restructuring Type [Axis]",
"terseLabel": "Restructuring Type [Axis]",
"verboseLabel": "Restructuring Cost and Reserve [Axis]"
}
}
},
"localname": "RestructuringCostAndReserveAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_RestructuringCostAndReserveLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Restructuring Cost and Reserve [Line Items]",
"terseLabel": "Restructuring Cost and Reserve [Line Items]"
}
}
},
"localname": "RestructuringCostAndReserveLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_RestructuringPlanAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by individual restructuring plan.",
"label": "Restructuring Plan [Axis]",
"terseLabel": "Restructuring Plan [Axis]"
}
}
},
"localname": "RestructuringPlanAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_RestructuringPlanDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Identification of the individual restructuring plans.",
"label": "Restructuring Plan [Domain]",
"terseLabel": "Restructuring Plan [Domain]"
}
}
},
"localname": "RestructuringPlanDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables"
],
"xbrltype": "domainItemType"
},
"us-gaap_RestructuringReserve": {
"auth_ref": [
"r216",
"r222"
],
"calculation": {
"http://www.labcorp.com/role/RestructuringReservesDetails": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
"label": "Restructuring Reserve",
"periodEndLabel": "Balance, end of period",
"periodStartLabel": "Balance, beginning of period",
"terseLabel": "Restructuring Reserve",
"totalLabel": "Total Restructuring Reserve"
}
}
},
"localname": "RestructuringReserve",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RestructuringReserveAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Restructuring Reserve [Abstract]"
}
}
},
"localname": "RestructuringReserveAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_RestructuringReserveAccrualAdjustment1": {
"auth_ref": [
"r215",
"r221"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
"label": "Restructuring Reserve, Accrual Adjustment",
"negatedLabel": "Reduction of prior restructuring accruals",
"negatedTerseLabel": "Reduction in total prior restructuring accruals"
}
}
},
"localname": "RestructuringReserveAccrualAdjustment1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RestructuringReserveCurrent": {
"auth_ref": [
"r215",
"r224"
],
"calculation": {
"http://www.labcorp.com/role/RestructuringReservesDetails": {
"order": 1.0,
"parentTag": "us-gaap_RestructuringReserve",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
"label": "Restructuring Reserve, Current",
"terseLabel": "Current",
"verboseLabel": "Restructuring Reserve, Current"
}
}
},
"localname": "RestructuringReserveCurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RestructuringReserveNoncurrent": {
"auth_ref": [
"r215"
],
"calculation": {
"http://www.labcorp.com/role/RestructuringReservesDetails": {
"order": 2.0,
"parentTag": "us-gaap_RestructuringReserve",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
"label": "Restructuring Reserve, Noncurrent",
"terseLabel": "Non-current",
"verboseLabel": "Restructuring Reserve, Noncurrent"
}
}
},
"localname": "RestructuringReserveNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RetainedEarningsAccumulatedDeficit": {
"auth_ref": [
"r34",
"r252",
"r409"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Retained Earnings (Accumulated Deficit)",
"negatedLabel": "Accumulated other comprehensive income"
}
}
},
"localname": "RetainedEarningsAccumulatedDeficit",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RetainedEarningsMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Retained Earnings [Member]",
"terseLabel": "Retained Earnings [Member]"
}
}
},
"localname": "RetainedEarningsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_RetirementPlanTypeAxis": {
"auth_ref": [
"r271",
"r272",
"r284",
"r285",
"r294"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
"label": "Retirement Plan Type [Axis]",
"terseLabel": "Retirement Plan Type [Axis]"
}
}
},
"localname": "RetirementPlanTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_RetirementPlanTypeDomain": {
"auth_ref": [
"r271",
"r272",
"r284",
"r285",
"r294"
],
"lang": {
"en-US": {
"role": {
"documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
"label": "Retirement Plan Type [Domain]",
"terseLabel": "Retirement Plan Type [Domain]"
}
}
},
"localname": "RetirementPlanTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_RevenueFromContractWithCustomerAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Revenue from Contract with Customer [Abstract]"
}
}
},
"localname": "RevenueFromContractWithCustomerAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_RevenueFromContractWithCustomerTextBlock": {
"auth_ref": [
"r270"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
"label": "Revenue from Contract with Customer [Text Block]",
"terseLabel": "Revenue from Contract with Customer [Text Block]"
}
}
},
"localname": "RevenueFromContractWithCustomerTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RevenueRemainingPerformanceObligation": {
"auth_ref": [
"r260"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
"label": "Revenue, Remaining Performance Obligation, Amount",
"terseLabel": "Revenue, Remaining Performance Obligation, Amount"
}
}
},
"localname": "RevenueRemainingPerformanceObligation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_Revenues": {
"auth_ref": [
"r79",
"r144",
"r145",
"r155"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 1.0,
"parentTag": "us-gaap_GrossProfit",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
"label": "Revenues",
"terseLabel": "Revenues"
}
}
},
"localname": "Revenues",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RevolvingCreditFacilityMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
"label": "Revolving Credit Facility [Member]",
"terseLabel": "Revolving Credit Facility [Member]"
}
}
},
"localname": "RevolvingCreditFacilityMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
"auth_ref": [
"r58"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
"label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
"terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
}
}
},
"localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
"auth_ref": [
"r69"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
"label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
"terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
"verboseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]"
}
}
},
"localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquity",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
"auth_ref": [
"r130"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
"label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
"terseLabel": "Potential common shares not included in computation of diluted earnings per share"
}
}
},
"localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/EarningsPerShareTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
"auth_ref": [
"r318",
"r319"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
"label": "Schedule of Business Acquisitions, by Acquisition [Table]",
"terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
}
}
},
"localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
"auth_ref": [
"r318",
"r319"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.",
"label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
"terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]"
}
}
},
"localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
"label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
"terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]"
}
}
},
"localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
"label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
"terseLabel": "Supplemental Cash Flow Information"
}
}
},
"localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/SupplementalCashFlowInformation",
"http://www.labcorp.com/role/SupplementalCashFlowInformationTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
"auth_ref": [
"r51",
"r114",
"r246",
"r249",
"r250",
"r251",
"r381",
"r382",
"r384",
"r404"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
"label": "Schedule of Long-term Debt Instruments [Table Text Block]",
"verboseLabel": "Long-term Debt [Text Block]"
}
}
},
"localname": "ScheduleOfDebtInstrumentsTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtLongTermDebtDetails"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
"auth_ref": [
"r284",
"r285",
"r287",
"r288",
"r293"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
"label": "Schedule of Defined Benefit Plans Disclosures [Table]",
"terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
}
}
},
"localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDefinedContributionPlansDetails",
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
"auth_ref": [
"r284",
"r285",
"r287",
"r288",
"r293"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
"label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
"terseLabel": "Schedule of Pensions and Postretirement Plans"
}
}
},
"localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PensionAndPostretirementPlansDetails"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
"auth_ref": [
"r347",
"r352",
"r356"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
"label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
"terseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]"
}
}
},
"localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivities"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
"auth_ref": [
"r116",
"r340",
"r342",
"r343",
"r344",
"r345",
"r350",
"r352",
"r357",
"r358"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
"label": "Schedule of Derivative Instruments [Table Text Block]",
"terseLabel": "Schedule of Derivative Instruments [Table Text Block]"
}
}
},
"localname": "ScheduleOfDerivativeInstrumentsTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivities"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
"auth_ref": [
"r131"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
"label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
"terseLabel": "Reconciliation of Basic earnings per Share to Diluted Earnings per Share"
}
}
},
"localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/EarningsPerShareTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
"auth_ref": [
"r195",
"r200"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
"label": "Schedule of Finite-Lived Intangible Assets [Table]",
"terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
"verboseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]"
}
}
},
"localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfGoodwillTable": {
"auth_ref": [
"r190",
"r192"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
"label": "Schedule of Goodwill [Table]",
"terseLabel": "Schedule of Goodwill [Table]"
}
}
},
"localname": "ScheduleOfGoodwillTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfGoodwillTextBlock": {
"auth_ref": [
"r190",
"r192"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
"label": "Schedule of Goodwill [Table Text Block]",
"terseLabel": "Changes in Carrying Amount of Goodwill"
}
}
},
"localname": "ScheduleOfGoodwillTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
"auth_ref": [
"r190"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
"label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
"terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]"
}
}
},
"localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
"auth_ref": [
"r218",
"r219",
"r223"
],
"lang": {
"en-US": {
"role": {
"documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
"label": "Schedule of Restructuring and Related Costs [Table]",
"terseLabel": "Schedule of Restructuring and Related Costs [Table]",
"verboseLabel": "Company's Restructuring Activities [Table]"
}
}
},
"localname": "ScheduleOfRestructuringAndRelatedCostsTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
"auth_ref": [
"r216",
"r224"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
"label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
"terseLabel": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]"
}
}
},
"localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
"auth_ref": [
"r143",
"r150",
"r151",
"r153",
"r190"
],
"lang": {
"en-US": {
"role": {
"documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
"label": "Schedule of Segment Reporting Information, by Segment [Table]",
"terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
}
}
},
"localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationNotes"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfShortTermDebtTable": {
"auth_ref": [
"r45"
],
"lang": {
"en-US": {
"role": {
"documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
"label": "Schedule of Short-term Debt [Table]",
"terseLabel": "Schedule of Short-term Debt [Table]"
}
}
},
"localname": "ScheduleOfShortTermDebtTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfShortTermDebtTextBlock": {
"auth_ref": [
"r45"
],
"lang": {
"en-US": {
"role": {
"documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
"label": "Schedule of Short-term Debt [Table Text Block]",
"terseLabel": "Short-term borrowings and current portion of long-term debt"
}
}
},
"localname": "ScheduleOfShortTermDebtTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ScheduleOfStockByClassTable": {
"auth_ref": [
"r53",
"r113",
"r242",
"r243",
"r244",
"r246",
"r247",
"r248",
"r249",
"r250",
"r251",
"r252"
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
"label": "Schedule of Stock by Class [Table]",
"terseLabel": "Schedule of Stock by Class [Table]"
}
}
},
"localname": "ScheduleOfStockByClassTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_SegmentDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
"label": "Segments [Domain]",
"terseLabel": "Segments [Domain]",
"verboseLabel": "Segments [Domain]"
}
}
},
"localname": "SegmentDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationNotes",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"us-gaap_SegmentReportingAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Segment Reporting [Abstract]",
"terseLabel": "Segment Reporting [Abstract]"
}
}
},
"localname": "SegmentReportingAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssets"
],
"xbrltype": "stringItemType"
},
"us-gaap_SegmentReportingDisclosureTextBlock": {
"auth_ref": [
"r161"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
"label": "Segment Reporting Disclosure [Text Block]",
"terseLabel": "Segment Reporting Disclosure [Text Block]"
}
}
},
"localname": "SegmentReportingDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationNotes"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SegmentReportingInformationLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Segment Reporting Information [Line Items]",
"terseLabel": "Segment Reporting Information [Line Items]"
}
}
},
"localname": "SegmentReportingInformationLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationNotes"
],
"xbrltype": "stringItemType"
},
"us-gaap_SelfPayMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Patients who pay out of pocket for a health-related service in absence of insurance to cover the medical or surgical procedure performed.",
"label": "Self-Pay [Member]",
"terseLabel": "Self-Pay [Member]"
}
}
},
"localname": "SelfPayMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "domainItemType"
},
"us-gaap_SellingGeneralAndAdministrativeExpense": {
"auth_ref": [
"r88",
"r176"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
"order": 2.0,
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
"label": "Selling, General and Administrative Expense",
"terseLabel": "Selling, general and administrative expenses"
}
}
},
"localname": "SellingGeneralAndAdministrativeExpense",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SeniorLongTermNotes": {
"auth_ref": [
"r51"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Senior note holders are paid off in full before any payments are made to junior note holders.",
"label": "Senior Notes, Noncurrent",
"terseLabel": "Senior Notes, Noncurrent"
}
}
},
"localname": "SeniorLongTermNotes",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails",
"http://www.labcorp.com/role/DebtSeniorNotesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_SeveranceCosts1": {
"auth_ref": [
"r104",
"r215",
"r220",
"r225"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
"label": "Severance Costs",
"terseLabel": "Restructuring charges related to severance and other employee costs",
"verboseLabel": "Severance Costs"
}
}
},
"localname": "SeveranceCosts1",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ShareBasedCompensation": {
"auth_ref": [
"r103"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of noncash expense for share-based payment arrangement.",
"label": "Share-based Payment Arrangement, Noncash Expense",
"terseLabel": "Stock compensation"
}
}
},
"localname": "ShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ShortTermDebtLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Short-term Debt [Line Items]",
"terseLabel": "Short-term Debt [Line Items]"
}
}
},
"localname": "ShortTermDebtLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShortTermDebtTypeAxis": {
"auth_ref": [
"r45"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of short-term debt arrangement.",
"label": "Short-term Debt, Type [Axis]",
"terseLabel": "Short-term Debt, Type [Axis]"
}
}
},
"localname": "ShortTermDebtTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtConvertibleSubordinatedNotesDetails",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ShortTermDebtTypeDomain": {
"auth_ref": [
"r43"
],
"lang": {
"en-US": {
"role": {
"documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
"label": "Short-term Debt, Type [Domain]",
"terseLabel": "Short-term Debt, Type [Domain]"
}
}
},
"localname": "ShortTermDebtTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtConvertibleSubordinatedNotesDetails",
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtShortTermBorrowingsAndCurrentPortionOfLongTermDebtTableDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ShorttermDebtFairValue": {
"auth_ref": [
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.",
"label": "Short-term Debt, Fair Value",
"terseLabel": "4.625% Senior notes due 2020"
}
}
},
"localname": "ShorttermDebtFairValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DerivativeInstrumentsAndHedgingActivitiesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StatementBusinessSegmentsAxis": {
"auth_ref": [
"r1",
"r150",
"r190",
"r212",
"r217",
"r226",
"r415"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by business segments.",
"label": "Segments [Axis]",
"terseLabel": "Segments [Axis]",
"verboseLabel": "Segments [Axis]"
}
}
},
"localname": "StatementBusinessSegmentsAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationDetails",
"http://www.labcorp.com/role/BusinessSegmentInformationBusinessSegmentInformationNotes",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringReservesDetails",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails",
"http://www.labcorp.com/role/RevenueTables"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementClassOfStockAxis": {
"auth_ref": [
"r29",
"r30",
"r31",
"r245"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by the different classes of stock of the entity.",
"label": "Class of Stock [Axis]",
"terseLabel": "Class of Stock [Axis]"
}
}
},
"localname": "StatementClassOfStockAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsTablesTables",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementEquityComponentsAxis": {
"auth_ref": [
"r55",
"r245"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by component of equity.",
"label": "Equity Components [Axis]",
"terseLabel": "Statement, Equity Components [Axis]",
"verboseLabel": "Equity Components [Axis]"
}
}
},
"localname": "StatementEquityComponentsAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquity",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityPreferredStockAndCommonShareholdersEquityAccumulatedOtherComprehensiveEarningsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Statement [Line Items]",
"terseLabel": "Statement [Line Items]"
}
}
},
"localname": "StatementLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"http://www.labcorp.com/role/LeasesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfCashFlowsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Cash Flows [Abstract]"
}
}
},
"localname": "StatementOfCashFlowsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfFinancialPositionAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Financial Position [Abstract]"
}
}
},
"localname": "StatementOfFinancialPositionAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfStockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Statement of Stockholders' Equity [Abstract]"
}
}
},
"localname": "StatementOfStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementTable": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
"label": "Statement [Table]",
"terseLabel": "Statement [Table]"
}
}
},
"localname": "StatementTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
"http://www.labcorp.com/role/LeasesDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": {
"auth_ref": [
"r30",
"r31",
"r245",
"r252"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.",
"label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures",
"negatedTerseLabel": "Surrender of restricted stock and performance share awards"
}
}
},
"localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
"label": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased",
"terseLabel": "Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased"
}
}
},
"localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
"auth_ref": [
"r30",
"r31",
"r245",
"r252"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares that have been repurchased and retired during the period.",
"label": "Stock Repurchased and Retired During Period, Shares",
"negatedTerseLabel": "Stock Repurchased and Retired During Period, Shares"
}
}
},
"localname": "StockRepurchasedAndRetiredDuringPeriodShares",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockRepurchasedDuringPeriodShares": {
"auth_ref": [
"r30",
"r31",
"r245",
"r252"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
"label": "Stock Repurchased During Period, Shares",
"terseLabel": "Stock Repurchased During Period, Shares"
}
}
},
"localname": "StockRepurchasedDuringPeriodShares",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockRepurchasedDuringPeriodValue": {
"auth_ref": [
"r30",
"r31",
"r245",
"r252"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
"label": "Stock Repurchased During Period, Value",
"negatedTerseLabel": "Purchase of common stock"
}
}
},
"localname": "StockRepurchasedDuringPeriodValue",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited",
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquity": {
"auth_ref": [
"r31",
"r35",
"r36",
"r166"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
"label": "Stockholders' Equity Attributable to Parent",
"periodEndLabel": "BALANCE",
"periodStartLabel": "BALANCE",
"terseLabel": "Stockholders' Equity Attributable to Parent",
"totalLabel": "Stockholders' Equity Attributable to Parent"
}
}
},
"localname": "StockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Stockholders' Equity Attributable to Parent [Abstract]",
"terseLabel": "Shareholders' equity:",
"verboseLabel": "Shareholders' Equity:"
}
}
},
"localname": "StockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockholdersEquityNoteAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Stockholders' Equity Note [Abstract]"
}
}
},
"localname": "StockholdersEquityNoteAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
"auth_ref": [
"r254"
],
"lang": {
"en-US": {
"role": {
"documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
"label": "Stockholders' Equity Note Disclosure [Text Block]",
"terseLabel": "Preferred Stock and Common Shareholders' Equity"
}
}
},
"localname": "StockholdersEquityNoteDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquity"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SubsequentEventLineItems": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
"label": "Subsequent Event [Line Items]",
"terseLabel": "Subsequent Event [Line Items]"
}
}
},
"localname": "SubsequentEventLineItems",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/SubsequentEventDetails",
"http://www.labcorp.com/role/SubsequentEventNotes"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventMember": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
"label": "Subsequent Event [Member]",
"terseLabel": "Subsequent Event [Member]"
}
}
},
"localname": "SubsequentEventMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/SubsequentEventDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_SubsequentEventTable": {
"auth_ref": [
"r387"
],
"lang": {
"en-US": {
"role": {
"documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
"label": "Subsequent Event [Table]",
"terseLabel": "Subsequent Event [Table]"
}
}
},
"localname": "SubsequentEventTable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/SubsequentEventDetails",
"http://www.labcorp.com/role/SubsequentEventNotes"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventTypeAxis": {
"auth_ref": [
"r387"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
"label": "Subsequent Event Type [Axis]",
"terseLabel": "Subsequent Event Type [Axis]"
}
}
},
"localname": "SubsequentEventTypeAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/SubsequentEventDetails",
"http://www.labcorp.com/role/SubsequentEventNotes"
],
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventTypeDomain": {
"auth_ref": [
"r387"
],
"lang": {
"en-US": {
"role": {
"documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
"label": "Subsequent Event Type [Domain]",
"terseLabel": "Subsequent Event Type [Domain]"
}
}
},
"localname": "SubsequentEventTypeDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/SubsequentEventDetails",
"http://www.labcorp.com/role/SubsequentEventNotes"
],
"xbrltype": "domainItemType"
},
"us-gaap_SubsequentEventsAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Subsequent Events [Abstract]"
}
}
},
"localname": "SubsequentEventsAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_SupplementalCashFlowInformationAbstract": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"label": "Supplemental Cash Flow Information [Abstract]"
}
}
},
"localname": "SupplementalCashFlowInformationAbstract",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
"auth_ref": [
"r268"
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by timing of transfer of good or service to customer.",
"label": "Timing of Transfer of Good or Service [Axis]",
"terseLabel": "Timing of Transfer of Good or Service [Axis]"
}
}
},
"localname": "TimingOfTransferOfGoodOrServiceAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
"label": "Timing of Transfer of Good or Service [Domain]",
"terseLabel": "Timing of Transfer of Good or Service [Domain]"
}
}
},
"localname": "TimingOfTransferOfGoodOrServiceDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_TradeNamesMember": {
"auth_ref": [
"r322"
],
"lang": {
"en-US": {
"role": {
"documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
"label": "Trade Names [Member]",
"terseLabel": "Trade Names [Member]"
}
}
},
"localname": "TradeNamesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_TrademarksAndTradeNamesMember": {
"auth_ref": [
"r322"
],
"lang": {
"en-US": {
"role": {
"documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
"label": "Trademarks and Trade Names [Member]",
"terseLabel": "Trademarks and Trade Names [Member]"
}
}
},
"localname": "TrademarksAndTradeNamesMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_TreasuryStockCarryingBasis": {
"auth_ref": [
"r253"
],
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Cost basis for treasury stock acquired for purposes other than retirement.",
"label": "Treasury Stock, Carrying Basis",
"terseLabel": "Treasury Stock, Carrying Basis"
}
}
},
"localname": "TreasuryStockCarryingBasis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/PreferredStockAndCommonShareholdersEquityDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_TreasuryStockMember": {
"auth_ref": [
"r54",
"r253"
],
"lang": {
"en-US": {
"role": {
"documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
"label": "Treasury Stock [Member]",
"terseLabel": "Treasury Stock [Member]"
}
}
},
"localname": "TreasuryStockMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_TypeOfRestructuringDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Identification of the types of restructuring costs.",
"label": "Type of Restructuring [Domain]",
"terseLabel": "Type of Restructuring [Domain]"
}
}
},
"localname": "TypeOfRestructuringDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesDetails",
"http://www.labcorp.com/role/RestructuringAndOtherSpecialChargesRestructuringAndOtherSpecialChargesDetailTables",
"http://www.labcorp.com/role/RestructuringReservesDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_UnbilledContractsReceivable": {
"auth_ref": [
"r57",
"r393"
],
"calculation": {
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
"order": 3.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-US": {
"role": {
"documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.",
"label": "Unbilled Contracts Receivable",
"terseLabel": "Unbilled Contracts Receivable"
}
}
},
"localname": "UnbilledContractsReceivable",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsDispositionsDetails",
"http://www.labcorp.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
"http://www.labcorp.com/role/RevenueDisaggregatedRevenueTableDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_UnrecognizedTaxBenefits": {
"auth_ref": [
"r300",
"r305"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount of unrecognized tax benefits.",
"label": "Unrecognized Tax Benefits",
"terseLabel": "Gross unrecognized income tax benefits"
}
}
},
"localname": "UnrecognizedTaxBenefits",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/IncomeTaxesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
"auth_ref": [
"r304"
],
"crdr": "credit",
"lang": {
"en-US": {
"role": {
"documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
"label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
"terseLabel": "Accrued interest and penalties related to unrecognized income tax benefits"
}
}
},
"localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/IncomeTaxesDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_UseOfEstimates": {
"auth_ref": [
"r134",
"r135",
"r136",
"r137",
"r138",
"r139",
"r140"
],
"lang": {
"en-US": {
"role": {
"documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
"label": "Use of Estimates, Policy [Policy Text Block]",
"terseLabel": "Use of Estimates, Policy [Policy Text Block]"
}
}
},
"localname": "UseOfEstimates",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BasisOfFinancialStatementPresentationUseOfEstimatesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_UseRightsMember": {
"auth_ref": [
"r326"
],
"lang": {
"en-US": {
"role": {
"documentation": "Legal right to use or benefit from the use of natural resources or access. Examples include, but are not limited to, drilling rights, water rights, air rights, timber cutting rights and route authorities.",
"label": "Use Rights [Member]",
"terseLabel": "Use Rights [Member]"
}
}
},
"localname": "UseRightsMember",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/BusinessAcquisitionsBusinessAcquisitionsInAggregateDetails",
"http://www.labcorp.com/role/BusinessAcquisitionsDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsChangesInCarryingAmountOfGoodwillDetails",
"http://www.labcorp.com/role/GoodwillAndIntangibleAssetsComponentsOfIdentifiableIntangibleAssetsDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_VariableRateAxis": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Information by type of variable rate.",
"label": "Variable Rate [Axis]",
"terseLabel": "Variable Rate [Axis]"
}
}
},
"localname": "VariableRateAxis",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_VariableRateDomain": {
"auth_ref": [
],
"lang": {
"en-US": {
"role": {
"documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
"label": "Variable Rate [Domain]",
"terseLabel": "Variable Rate [Domain]"
}
}
},
"localname": "VariableRateDomain",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/DebtCreditFacilitiesDetails",
"http://www.labcorp.com/role/DebtLongTermDebtDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
"auth_ref": [
"r124",
"r129"
],
"lang": {
"en-US": {
"role": {
"documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
"label": "Weighted Average Number of Shares Outstanding, Diluted",
"terseLabel": "Weighted Average Number of Shares Outstanding, Diluted"
}
}
},
"localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/EarningsPerShareReconciliationOfBasicEarningsPerShareToDilutedEarningsPerShareDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
"auth_ref": [
"r122",
"r129"
],
"lang": {
"en-US": {
"role": {
"documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
"label": "Weighted Average Number of Shares Outstanding, Basic",
"terseLabel": "Net earnings, basic (in shares)"
}
}
},
"localname": "WeightedAverageNumberOfSharesOutstandingBasic",
"nsuri": "http://fasb.org/us-gaap/2019-01-31",
"presentation": [
"http://www.labcorp.com/role/EarningsPerShareReconciliationOfBasicEarningsPerShareToDilutedEarningsPerShareDetails"
],
"xbrltype": "sharesItemType"
}
},
"unitCount": 5
}
},
"std_ref": {
"r0": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
},
"r1": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
},
"r10": {
"Name": "Accounting Standards Codification",
"Paragraph": "5C",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
},
"r100": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585"
},
"r101": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
},
"r102": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
},
"r103": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
},
"r104": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
},
"r105": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
},
"r106": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
},
"r107": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586"
},
"r108": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
},
"r109": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586"
},
"r11": {
"Name": "Accounting Standards Codification",
"Paragraph": "5D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
},
"r110": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586"
},
"r111": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "230",
"URI": "http://asc.fasb.org/topic&trid=2134446"
},
"r112": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(h))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r113": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(d),(e))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r114": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(e),(f))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r115": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(f))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r116": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08.(n)(2))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
},
"r117": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "235",
"URI": "http://asc.fasb.org/topic&trid=2122369"
},
"r118": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(3)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
},
"r119": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
},
"r12": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
},
"r120": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
},
"r121": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "250",
"URI": "http://asc.fasb.org/topic&trid=2122394"
},
"r122": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
},
"r123": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256"
},
"r124": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
},
"r125": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
},
"r126": {
"Name": "Accounting Standards Codification",
"Paragraph": "28A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256"
},
"r127": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
},
"r128": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
},
"r129": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r13": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "205",
"URI": "http://asc.fasb.org/topic&trid=2122149"
},
"r130": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r131": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
},
"r132": {
"Name": "Accounting Standards Codification",
"Paragraph": "52",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
},
"r133": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "260",
"URI": "http://asc.fasb.org/topic&trid=2144383"
},
"r134": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r135": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r136": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
},
"r137": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
},
"r138": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
},
"r139": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
},
"r14": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r140": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
},
"r141": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "275",
"URI": "http://asc.fasb.org/topic&trid=2134479"
},
"r142": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8657-108599"
},
"r143": {
"Name": "Accounting Standards Codification",
"Paragraph": "21",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599"
},
"r144": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r145": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r146": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r147": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r148": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r149": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r15": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r150": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
},
"r151": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
},
"r152": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
},
"r153": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
},
"r154": {
"Name": "Accounting Standards Codification",
"Paragraph": "31",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599"
},
"r155": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
},
"r156": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
},
"r157": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
},
"r158": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
},
"r159": {
"Name": "Accounting Standards Codification",
"Paragraph": "41",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
},
"r16": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r160": {
"Name": "Accounting Standards Codification",
"Paragraph": "42",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9054-108599"
},
"r161": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "280",
"URI": "http://asc.fasb.org/topic&trid=2134510"
},
"r162": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
},
"r163": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
},
"r164": {
"Name": "Accounting Standards Codification",
"Paragraph": "11B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=118936363&loc=SL6953423-111524"
},
"r165": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524"
},
"r166": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 4.E)",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
},
"r167": {
"Name": "Accounting Standards Codification",
"Paragraph": "8A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "320",
"URI": "http://asc.fasb.org/extlink&oid=118954083&loc=SL6284422-111562"
},
"r168": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "323",
"URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
},
"r169": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "323",
"URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
},
"r17": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r170": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(1)",
"Topic": "323",
"URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r171": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446"
},
"r172": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
},
"r173": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
},
"r174": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(f)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
},
"r175": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
},
"r176": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "30",
"SubTopic": "10",
"Topic": "330",
"URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
},
"r177": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "35",
"SubTopic": "10",
"Topic": "330",
"URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
},
"r178": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "05",
"SubTopic": "10",
"Topic": "340",
"URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
},
"r179": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(b)",
"Topic": "340",
"URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131251-203054"
},
"r18": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
},
"r180": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(a)",
"Topic": "340",
"URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
},
"r181": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Subparagraph": "(b)",
"Topic": "340",
"URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
},
"r182": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Topic": "340",
"URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
},
"r183": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
},
"r184": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
},
"r185": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
},
"r186": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
},
"r187": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(e)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
},
"r188": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(f)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
},
"r189": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(g)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
},
"r19": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765"
},
"r190": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
},
"r191": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
},
"r192": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
},
"r193": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
},
"r194": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
},
"r195": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r196": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(1)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r197": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(3)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r198": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
},
"r199": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "((a)(1),(b))",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r2": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
},
"r20": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
},
"r200": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r201": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(1)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r202": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(2)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r203": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(3)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r204": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r205": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
},
"r206": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "350",
"URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
},
"r207": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "350",
"URI": "http://asc.fasb.org/topic&trid=2144416"
},
"r208": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
},
"r209": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
},
"r21": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765"
},
"r210": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
},
"r211": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
},
"r212": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
},
"r213": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
},
"r214": {
"Name": "Accounting Standards Codification",
"Paragraph": "3A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "360",
"URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
},
"r215": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
},
"r216": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(2)",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
},
"r217": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
},
"r218": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
},
"r219": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB TOPIC 5.P.3)",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
},
"r22": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(19)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r220": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 5.P.3)",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
},
"r221": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
},
"r222": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB TOPIC 5.P.4(b))",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
},
"r223": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB TOPIC 5.P.4)",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
},
"r224": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 5.P.4(b)(2))",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
},
"r225": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 5.P.4(b))",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
},
"r226": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 5.P.4(d))",
"Topic": "420",
"URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
},
"r227": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "420",
"URI": "http://asc.fasb.org/topic&trid=2175745"
},
"r228": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "440",
"URI": "http://asc.fasb.org/topic&trid=2144648"
},
"r229": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
},
"r23": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(13))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r230": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349"
},
"r231": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349"
},
"r232": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
},
"r233": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349"
},
"r234": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349"
},
"r235": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
},
"r236": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "450",
"URI": "http://asc.fasb.org/topic&trid=2127136"
},
"r237": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "460",
"URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248"
},
"r238": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "460",
"URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248"
},
"r239": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
},
"r24": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(14))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r240": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870"
},
"r241": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "470",
"URI": "http://asc.fasb.org/topic&trid=2208564"
},
"r242": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(CFRR 211.02)",
"Topic": "480",
"URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
},
"r243": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
},
"r244": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
},
"r245": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
},
"r246": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
},
"r247": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
},
"r248": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
},
"r249": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
},
"r25": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(19))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r250": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
},
"r251": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
},
"r252": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.3-04)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
},
"r253": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
},
"r254": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "505",
"URI": "http://asc.fasb.org/topic&trid=2208762"
},
"r255": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044"
},
"r256": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044"
},
"r257": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044"
},
"r258": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045"
},
"r259": {
"Name": "Accounting Standards Codification",
"Paragraph": "12A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL108322424-203045"
},
"r26": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(20))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r260": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045"
},
"r261": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
},
"r262": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
},
"r263": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
},
"r264": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
},
"r265": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
},
"r266": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
},
"r267": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
},
"r268": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
},
"r269": {
"Name": "Accounting Standards Codification",
"Paragraph": "91",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
},
"r27": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(22))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r270": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "606",
"URI": "http://asc.fasb.org/topic&trid=49130388"
},
"r271": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "15",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "712",
"URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
},
"r272": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "15",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "712",
"URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
},
"r273": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
},
"r274": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)(1)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r275": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)(2)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r276": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r277": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(ii)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r278": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(d)(iv)(01)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r279": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(h)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r28": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(24))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r280": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(h)(1)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r281": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(h)(2)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r282": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(h)(3)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r283": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(n)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r284": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
},
"r285": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
},
"r286": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
},
"r287": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
},
"r288": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
},
"r289": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
},
"r29": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(27))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r290": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)(1)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
},
"r291": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)(2)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
},
"r292": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)(3)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
},
"r293": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
},
"r294": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "70",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
},
"r295": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "715",
"URI": "http://asc.fasb.org/topic&trid=2235017"
},
"r296": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "35",
"SubTopic": "10",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899"
},
"r297": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
},
"r298": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907"
},
"r299": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907"
},
"r3": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
},
"r30": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(28))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r300": {
"Name": "Accounting Standards Codification",
"Paragraph": "10B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318"
},
"r301": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31917-109318"
},
"r302": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
},
"r303": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
},
"r304": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
},
"r305": {
"Name": "Accounting Standards Codification",
"Paragraph": "15A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
},
"r306": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
},
"r307": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
},
"r308": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB TOPIC 6.I)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
},
"r309": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 6.I.7)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
},
"r31": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(29))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r310": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e39076-109324"
},
"r311": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
},
"r312": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(d)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
},
"r313": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "740",
"URI": "http://asc.fasb.org/topic&trid=2144680"
},
"r314": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
},
"r315": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)(2)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r316": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)(3)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r317": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)(4)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r318": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
},
"r319": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
},
"r32": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r320": {
"Name": "Accounting Standards Codification",
"Paragraph": "37",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464"
},
"r321": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
},
"r322": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
},
"r323": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(e)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
},
"r324": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473"
},
"r325": {
"Name": "Accounting Standards Codification",
"Paragraph": "31",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5419-128473"
},
"r326": {
"Name": "Accounting Standards Codification",
"Paragraph": "31",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "20",
"Subparagraph": "(i)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5419-128473"
},
"r327": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(a)(1)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479"
},
"r328": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "805",
"URI": "http://asc.fasb.org/topic&trid=2303972"
},
"r329": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
},
"r33": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r330": {
"Name": "Accounting Standards Codification",
"Paragraph": "19",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
},
"r331": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(1)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r332": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(2)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r333": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r334": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c),(3)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r335": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
},
"r336": {
"Name": "Accounting Standards Codification",
"Paragraph": "4J",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686"
},
"r337": {
"Name": "Accounting Standards Codification",
"Paragraph": "4K",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686"
},
"r338": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "810",
"URI": "http://asc.fasb.org/topic&trid=2197479"
},
"r339": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958"
},
"r34": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r340": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
},
"r341": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
},
"r342": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
},
"r343": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
},
"r344": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
},
"r345": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
},
"r346": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
},
"r347": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
},
"r348": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
},
"r349": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
},
"r35": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r350": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
},
"r351": {
"Name": "Accounting Standards Codification",
"Paragraph": "4C",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
},
"r352": {
"Name": "Accounting Standards Codification",
"Paragraph": "4C",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
},
"r353": {
"Name": "Accounting Standards Codification",
"Paragraph": "4D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
},
"r354": {
"Name": "Accounting Standards Codification",
"Paragraph": "4D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
},
"r355": {
"Name": "Accounting Standards Codification",
"Paragraph": "4D",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
},
"r356": {
"Name": "Accounting Standards Codification",
"Paragraph": "4E",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
},
"r357": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
},
"r358": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
},
"r359": {
"Name": "Accounting Standards Codification",
"Paragraph": "182",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961"
},
"r36": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(31))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r360": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "25",
"Subparagraph": "(a)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
},
"r361": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "25",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
},
"r362": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "815",
"URI": "http://asc.fasb.org/topic&trid=2229140"
},
"r363": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r364": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r365": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bb)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r366": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r367": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1a)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r368": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
},
"r369": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
},
"r37": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(32))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r370": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
},
"r371": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
},
"r372": {
"Name": "Accounting Standards Codification",
"Paragraph": "5A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610"
},
"r373": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611"
},
"r374": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "35",
"SubTopic": "20",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118948100&loc=d3e30304-110892"
},
"r375": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "230",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
},
"r376": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
},
"r377": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r378": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(b,d)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r379": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
},
"r38": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(5))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r380": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
},
"r381": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
},
"r382": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
},
"r383": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
},
"r384": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "30",
"Topic": "835",
"URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
},
"r385": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "25",
"SubTopic": "20",
"Subparagraph": "(c)",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=77888369&loc=SL77918431-209957"
},
"r386": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "20",
"Subparagraph": "(b)",
"Topic": "842",
"URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
},
"r387": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "855",
"URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
},
"r388": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "855",
"URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
},
"r389": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
},
"r39": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(6)(d)(i))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r390": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)(1)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
},
"r391": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)(2)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
},
"r392": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(bb)(3)",
"Topic": "860",
"URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
},
"r393": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "310",
"Topic": "912",
"URI": "http://asc.fasb.org/extlink&oid=118261985&loc=d3e55302-109406"
},
"r394": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "340",
"Topic": "928",
"URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
},
"r395": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(11))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r396": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(13))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r397": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(15)(5))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r398": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(16))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r399": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(23))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
},
"r4": {
"Name": "Accounting Standards Codification",
"Paragraph": "3A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
},
"r40": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.1)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r400": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(13)(f))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
},
"r401": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(22))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
},
"r402": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(23))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
},
"r403": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04.9)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
},
"r404": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "470",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
},
"r405": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(16))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r406": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(12))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r407": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(15)(a))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r408": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(16))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r409": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r41": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.12)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r410": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(25))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r411": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(8))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
},
"r412": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(10))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
},
"r413": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(18))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
},
"r414": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(19))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
},
"r415": {
"Name": "Accounting Standards Codification",
"Paragraph": "4H",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "40",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
},
"r416": {
"Name": "Accounting Standards Codification",
"Paragraph": "13H",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "40",
"Subparagraph": "(a)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
},
"r417": {
"Name": "Accounting Standards Codification",
"Paragraph": "13H",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "40",
"Subparagraph": "(b)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
},
"r418": {
"Name": "Accounting Standards Codification",
"Paragraph": "13H",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "40",
"Subparagraph": "(c)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
},
"r419": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "310",
"Subparagraph": "(SX 210.12-29(Footnote 4))",
"Topic": "948",
"URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014"
},
"r42": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.17)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r420": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "360",
"Subparagraph": "(SX 210.12-28(Footnote 2))",
"Topic": "970",
"URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
},
"r421": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b"
},
"r422": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "d1-1"
},
"r423": {
"Name": "Form 10-Q",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-13"
},
"r424": {
"Name": "Forms 10-K, 10-Q, 20-F",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-1-"
},
"r425": {
"Name": "Regulation 12B",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b-2"
},
"r426": {
"Name": "Regulation S-T",
"Number": "232",
"Publisher": "SEC",
"Section": "405"
},
"r43": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19(a))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r44": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19(b),22(b))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r45": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r46": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19,20)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r47": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19-26)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r48": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.20)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r49": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.21)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r5": {
"Name": "Accounting Standards Codification",
"Paragraph": "4A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
},
"r50": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.22(a)(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r51": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.22)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r52": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.24)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r53": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.28,29)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r54": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.29,30)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r55": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.29-31)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r56": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.3(b))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r57": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.3(c)(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r58": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.3,4)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r59": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.31)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r6": {
"Name": "Accounting Standards Codification",
"Paragraph": "4B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
},
"r60": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.6(a))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r61": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.9)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
},
"r62": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r63": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r64": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(i-k)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r65": {
"Name": "Accounting Standards Codification",
"Paragraph": "10A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
},
"r66": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
},
"r67": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580"
},
"r68": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
},
"r69": {
"Name": "Accounting Standards Codification",
"Paragraph": "14A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
},
"r7": {
"Name": "Accounting Standards Codification",
"Paragraph": "5A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
},
"r70": {
"Name": "Accounting Standards Codification",
"Paragraph": "17B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
},
"r71": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
},
"r72": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
},
"r73": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
},
"r74": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
},
"r75": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
},
"r76": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
},
"r77": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
},
"r78": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(210.5-03(11))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r79": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(1))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r8": {
"Name": "Accounting Standards Codification",
"Paragraph": "5B",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
},
"r80": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(12))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r81": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(20))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r82": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(21))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r83": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(5))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r84": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.1,2)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r85": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.19)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r86": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.2)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r87": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.3)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r88": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.4)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r89": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.7(a),(b))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r9": {
"Name": "Accounting Standards Codification",
"Paragraph": "5C",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(a)(2)",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
},
"r90": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.7)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r91": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.8)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r92": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.9)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
},
"r93": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
},
"r94": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
},
"r95": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
},
"r96": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
},
"r97": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
},
"r98": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
},
"r99": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
}
},
"version": "2.1"
} |
